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GENERAL INTRODUCTION.
Eor many years it had been, clear that a 
reliable means of assessing placental function would 
provide clinicians with a valuable tool, in controlling 
treatment and guiding the prognosis, in abnormal 
pregnancy conditions. The placenta is known to 
produce an enormously wide variety of substances, 
directly or indirectly influencing foetal development. 
Some of these are incapable of assessment and are not 
produced continuously during pregnancy. Others 
are in constant production and because they give 
rise to well recognised excretion products lend 
themselves to a study of placental function.
Oestrogens and progesterone are examples of such 
products, but whereas the chemical nature of the 
various end products of oestrogen metabolism has not 
been fully investigated, it has long been recognised 
that sodium pregnanediol glycuronide forms a major 
part of the katabolites derived from progesterone.
Various methods have been formulated for the 
urinary pregnanediol estimation. It may be 
estimated in conjugated form, Sodium Pregnanediol 
Glycuronide ^/Na.P.G^ (Venning, 1937, Allan &
Viergiver, 1941; Kaufman & Westphal, 1947) or as 
free pregnanediol (Davis & Fugo, 1947; G-uterman 
1947; Sommerville, Gough & Marrian, 1948; de 
Watteville, 1952, Klopper, Michie & Browne, 1955)* 
Before this work was undertaken considerable 
controversy existed regarding the normal range of 
values and the clinical significances of pregnanediol 
excretion. Thus the values given for the peak 
excretion in the last months of pregnancy vary 
according to different workers:- Venning (1937)
72 + 22, Davis & Fugo (1947) 73 + 12, Michie (1953)
62 + 21, de Watteville (1951) 49+ 12 and Kaufman, 
Westphal & Zander (1951) 2 2 + 2 2 .
Pregnanediol is one of the excretory end 
products of progesterone metabolism produced in the 
secretory phase of the normal menstrual cycle and 
throughout pregnancy. Progesterone is essential for 
the embedding and growth of the early ovum. Many 
observers have thought that lack of progesterone was 
related to imperfect embedding and abortion, the 
pregnanediol assay has been advocated as a guide to 
prognosis and therapy in threatened and recurrent 
abortions (Cope, 1940; Hain, 1941 and Bender, 1948). 
Others have found it of limited value in these
conditions Swyer & Daly (1953) and de Watteville 
(1951).
The placenta takes over the function of the 
corpus luteum after the 3rd month of pregnancy 
where a rise in the level of pregnanediol excretion 
is noted. Late pregnancy disorders may be associated 
with a drop in progesterone production and hence a 
fall in the pregnanediol excretion. Smith & Smith 
(1954) showed that when regular assays were performed 
on 104 normal pregnant women the excretion dropped 
or failed to rise 3 to 5 days before the patients 
showed signs of toxaemia. Venning (1938); Hain 
(1941); and de Watteville (1951) failed to find 
any correlation between the pregnanediol excretion 
and the degree of toxaemia, but they found that in 
certain cases where there was danger of intrauterine 
foetal death there was also a low pregnanediol 
excretion. Trolle (1955) suggested that the 
presence of albumen in the urine in these cases 
might give rise to fallacious results, The albumen 
inducing, during toluene extraction, the formation 
of a firm emulsion, making recovery of pregnanediol 
difficult.
In chronic nephritis associated with 
essential hypertension, Pigeaud, Burthiault & 
Bertoux (1954) found that the pregnanediol 
excretion was low if intrauterine foetal death 
occurred. This was not so when chronic nephritis 
alone was present.
White & Hunt (194-0) , White (1949) and Smith 
& Smith (1947) showed that in the diabetic patient 
low pregnanediol values were associated with intra­
uterine foetal death. Peel (1955) stated that a 
fall in excretion of pregnanediol preceeded the 
foetal death in diabetes, but Gray (1955) was unable 
to show any significant difference between the 
results obtained in diabetic and in normal pregnant 
women.
The conflicting views in the literature cited 
showed that no clear picture of the normal range 
of pregnanediol excretion in pregnancy or of the 
variations which occur in early or late abnormal 
pregnancy^ could be obtained, and it was decided 
therefore to make a more comprehensive study of 
the problem. The first part of the work comprises 
an investigation into the variations which occur
when different methods are used to extract and 
purify pregnanediol. A review of the literature 
showed that by the method used by Sommerville et al 
(1948) a purer extract was obtained than by any of 
the shorter methods. This method was chosen for 
comparison with a modification of the method of 
Henderson et al (1949) which had been in current 
use at the Jessop Hospital for Women, Sheffield 
for the previous five years. Since neither of 
these methods proved to be satisfactory, an 
analysis was made of a new chromatographic method 
by Klopper, f'Michie & Brown (1955)• This method 
was found to give a purer extract and it was adopted 
subsequently for all the work on the pregnanediol 
excretion in normal and abnormal pregnancy described 
below.
The investigaticnfell into 4 divisions:-
SECTION I. METHODS.
Part A . Methods of Determining the Urinary
Pregnanediol. This consists of a 
comparison between the method of 
Sommerville, Marrian and Gough (1948), 
and of Mitchell (1954).
Part B . Critical review of the method of Klopper,
: Michie and Brown (1955)•
Part C . The relationship between the Blood
"progestational activity", estimated by 
the Hooker and Forbes (1947) biological 
assay and the urinary pregnanediol excretion 
in normal pregnancy.
SECTION II. NORMAL PREGNANCY.
The range of pregnanediol excretion during 
normal pregnancy, before the onset of labour 
and in the puerperium was investigated.
SECTION III. ABNORMAL EARLY PREGNANCY.
The pregnanediol excretion in cases of 
threatened abortion, recurrent abortion 
and in Hydatidiform mole was investigated.
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SECTION IV. ABNORMAL LATE PREGNANCY.
Part A . The pregnanediol excretion in the Toxaemias
of Pregnancy. The following conditions 
were investigated
A) Pre-eclamptic toxaemia
B) Essential Hypertension
C) Stillbirths and neonatal deaths 
associated with Toxaemia
D) Chronic renal disease
Part B . The pregnanediol excretion in conditions
associated with foetal death in late 
pregnancy. The following conditions were 
investigated:-
A) Antepartum Haemorrhage
B) Diabetes mellitus
C) Rhesus immunisation including cases 
of unexplained foetal death
D) Bad obstetric history.
Each section begins with a short introduction which 
includes references to the literature and it is 
concluded by a general discussion. A summary of the 
work reported and the conclusion drawn from it 
completes the thesis.
SECTION I .
Part A . ERRORS IN THE DETERMINATION OP THE 
URINARY PREG-NANEDIOL EXCRETION.
This section presents the results of a study 
of the variations found in the pregnanediol 
excretion in late pregnancy when a detailed 
examination of two methods of assay was made, 
together with a brief review of previous clinical 
experiences with these methods in the light of the 
results obtained.
INTRODUCTION.
Marrian isolated pregnanediol from the urine 
of pregnant women in 1929 and the chemical constitution 
was determined by Butenandt (1930 & 1931) who named 
the substance pregnanediol. Progesterone was 
isolated as a chemically pure substance in 1934.
There is a striking relationship between these 
steroids and Venning & Browne (1936) demonstrated that 
sodium pregnanediol glycuronide could be recovered 
from the urine in the second half of the menstrual 
cycle and in pregnancy. Venning, Henry & Browne 
(1937) showed that when progesterone was injected 
into post-menopausal women and men pregnanediol was
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recovered from the urine.
Pregnanediol can either he estimated as "free 
pregnanediol” or in the conjugated form, sodium 
pregnanediol glycuronide /la P.G/7. In the method 
used by Venning (1937) the /la P . G ^  is recovered 
from the urine by extraction with butyl alcohol and 
subsequent precipitation from acetone. This method 
was later modified by Allan & Viergiver (1941) and 
Kaufman & Westphal (1947)• It requires large 
quantities of urine and the final extract contains 
only 80 per cent of the /la P.GjJ7 extracted, (Marrian 
& G-ough, 1946)* Moreover, bacterial hydrolysis of 
the /la P s o m e t i m e s  occurs and this causes 
misleading low recoveries, (Bucher & Geschicter,
1940).
Astwood & Jones (1941) hydrolysed the urine 
by boiling with acid and estimated the "free 
pregnanediol" gravimetrically. "Pree pregnanediol" 
when treated with concentrated sulphuric acid gives 
a yellow colour, and Talbot, Berman, Maclaglan &
Wolfe (1941) used this to devise a colorimetric 
method for estimating the pregnanediol.
Sommerville, G-ough & Marrian (194-8) increased 
the purity of the final extract by the introduction 
of fractional precipitation of the pregnanediol 
extract. Modified precipitation techniques are 
used in the shorter methods of G-uterman (1944) and 
of Sommerville, Marrian & Kellar (1948) but both 
these modifications reduce the accuracy and the 
specificity of the extraction process.
Other methods purify the pregnanediol by 
chromatography, Stimel, Randolf & Conn (1952),
Huber (1947) and de Watteville (1951), but 
impurities are still present in their final extracts. 
These may be removed by washing with cold solvents, 
but this causes a considerable loss of the free 
pregnanediol. (Bradshaw & Jessop, 1953? and Klopper, 
Michie & Browne 1955)•
When "free pregnanediol" is estimated, the 
final measurement is made either by a non-specific 
colour reaction obtained by adding concentrated 
sulphuric acid to the dried extract or by weighing 
it. The accuracy of the gravimetric method is 
dependent upon the purity of the residue and this 
may be determined by comparison of the melting
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point and the absorption in ultraviolet light 
of the final extract with those of pure pregnanediol. 
These considerations led to the selection of the 
method of Sommerville, G-ough & Marrian (1948) and 
to that of Henderson, Maclaghan, Wheatley &
Wilkinson (1949), because they gave a white 
crystalline extract, and no loss was entailed by 
leaching the extract with cold solvents to purify.
DESIGN OF EXPERIMENT.
Three consecutive 24 hour specimens of urine 
were collected from 10 normal primigravid patients 
in the 34th - 35th week of pregnancy. Every care 
was taken to ensure a complete 24 hour specimen 
in each case; also the volume and creatinine 
content of each specimen of urine were noted and 
where these showed a marked daily variation the 
specimens were discarded and others obtained: this
was only necessary on 2 occasions. Purified extracts 
were prepared in duplicate by myself and a technician. 
One of us used the method of Sommerville et al (1948) 
and the other used that of Henderson et al (1949)•
The pregnanediol content was estimated gravimetrically
and colorimetrically on each specimen of urine by 
both methods. The gravimetric extracts were also 
examined for purity by melting point determinations 
and absorption in ultraviolet light. Each patient 
was kept under observation until delivery when the 
weight of the baby, and the weight, macroscopic 
appearance and histology of the placenta were noted.
METHOD I.
The method of Sommerville et al (1948) was 
used without major modification. The urine (500 
ml.) after acid hydrolysis, was extracted with toluene, 
and any emulsion obtained was broken down by the 
addition of a few drops of Teepol (Shell Chemicals, 
Ltd., London) instead of the tedious filtration 
process used by Sommerville and his colleagues; 
this modification was shown not to interfere with 
the extraction. The toluene extract was washed with 
N-NaOH and water and evaporated to dryness; the 
residue was then dissolved in ethanol and precipitated 
under carefully controlled conditions of time and 
temperature,onc@ with 0.1 N-NaOH and twice with 
water, the precipitate in each case being controlled
by centrifugation with the aid of Hyflo Super-Cell 
(Johns Manville Co.,Ltd., London). After final 
decolonization with charcoal in ethanol, concentrated 
sulphuric acid was added to a portion of the dried 
extract which was than placed for 24 minutes in a 
water bath at 25°C ; "the absorption of the solution was 
then measured in the Spekker Photoelectric Absorptiometer 
using an Ilford Spectrum Violet 601 Pilter (transmission 
max. 403 atpc) . The remainder of the dried extract 
was weighed to give an alternative method of estimation.
METHOD II.
Henderson et al (1949) used a precipitation 
from acetone because this solvent appeared,from 
preliminary work,to give the best results. They 
showed that the time and temperature of precipitation 
from acetone were not determining factors in the 
recovery of added pregnanediol, and, as pregnanediol 
is less soluble in acetone than in ethanol, recovery 
from acetone should compare favourably with that 
obtained by the method of Sommerville et al (1948).
In the original method Henderson et al (1949) 
used only one precipitation; for Method II, the two
techniques have been combined, in that three 
precipitations from acetone instead of ethanol 
were used.
The dried toluene residue obtained as for 
Method I was taken up in 2.5 ml. acetone in a 50 ml 
centrifuge and 50 ml. IN-NaOH was added. The 
mixture was stirred and placed in a boiling water 
bath for 10 minutes and subsequently transferred 
to a refrigerator at 4^ for 2 hours. Hyflo Super- 
Cel 10 mg. was then added, with stirring, and the 
tube was centrifuged at 2,500 r.p.m. for 20 minutes 
The supernatant liquid was decanted and the 
precipitation twice repeated on the residue using 
distilled water instead of 0.1 N-NaOH. The 
remainder of the procedure was as for Method I.
Recovery experiments were carried out for 
comparison with Method I. One precipitation using 
pure pregnanediol, pure solvents and 0.1 1-laOH or 
distilled water, gave similar results for both 
methods; but when pure pregnanediol was added 
to male urine (0.5 - 2.0 mg. added to 500 ml. of 
urine) the recoveries using each technique in full
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were approximately 10$ less for Method II than for 
Method I: this discrepancy was greater when
pregnancy urine was examined. As the final product 
from pregnancy urine using either method was not 
pure pregnanediol, this discrepancy could be due to 
a difference in the amount of impurity present.
RESULTS Of THE EXPERIMENT.
The duplicate readings were first examined and 
the differences between pairs of readings analysed.
The mean difference of duplicate readings in Methods 
I and II was 3-9 + 9*57 (standard error of mean of 
30 observations) and 2.5 + 0.38 (30): showing that 
the technical accuracy of the two methods was 
similar. The duplicate readings were therefore 
averaged leaving 4- estimations of pregnanediol for 
each of the 10 patients on each of 3 hays, making 
120 estimations in all (Table I).
The marginal totals shown in Table I indicate 
the main results of the experiment. There is a 
large difference between individual patients and a 
small difference (not significant) between days, 
which may be ignored in view of the other and more
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important findings. There are marked differences 
between the results for Method I and for Method II 
and between the gravimetric and colorimetric 
estimations, differences which are far greater 
than could possibly be the result of chance 
variation. These observations, together with 
the high mean square error, suggested that all 
four estimates were at fault, and this was shown 
to be the case when the final products were tested 
for purity by measuring their melting point and 
ultraviolet absorption spectra (Table II).
The average melting point for the product 
of Method I was 207°+ 1.8° (standard error of the 
mean of 32 observations), and for Method II 219° + 
2.2°(4l), levels which were clearly different from 
those of pure pregnanediol (243°)> all melting 
points being measured on a G-allencamp (London) 
stage. Though Method I gave estimations for 
pregnanediol twice those for Method II (see totals 
Table I), the higher melting point of the final 
extract of Method II indicated that this method 
gave the purer products.
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Case ■ Duration Babies' Placental Macroscopic appear-
No. of Weight Weight and or Placenta
Pregnancy 
at
delivery
1
3£
2
41 weeks 8 lb. 1302, 1 lb. 14oz. Pew small infarcts 
present
39* H 6 lb. 3 oz. 1 lb. 3oz. Unhealthy "giitty" 
apx^ earance. Long 
cord. No infarcts.
3 u it 8 lb. 1 oz. 1 lb. 3oz. Pew small infarcts 
present.
4 43 it 8 lb. 1 oz. 1 lb. 8oz. " Gri t ty1 app eararic e 
Pew small infarcxs.
p; k0 it 4 lb. 9 oz. 1 lb. 2oz. Small but healthy.
6 40 it 8 lb. 6 oz. 1 lb. 8oz. Healthy.
-? 3E
14 it 9 lb. 7 oz. 1 lb. 12oz. Unhealthy “gritty1' 
appearance.
8 T m i it . 6 lb. 13 oz. 1 lb. lloz. Healthy. Pew 
small infarcts.
9 41 it 6 lb. 12oz. 1 lb. 3oz. Healthy.
10 40 H 7 lb. 5oz. 1 lb. 3oz. Healthy with few 
small infarcts.
* In case 2 there was marked foetal distress 
But a living child was obtained.
3t In case 7 the infant was stillborn.
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The ultraviolet absortion spectra were 
measured in ethanolic solution and peaks or 
inflections were obtained in all cases at approxi­
mately 204 and 230 mu. The average values for
E i^ om for Methods I and II at 204 m}i. were 
4 1 + 2 . 7  (30) and 5 7 + 5 - 9  (30) and at 203 mg|* 
the corresponding values were 2 8 + 2 . 2  (30) and 
32 + 3*9 (30). As pregnanediol at the concentration 
and within the range investigated has a negligable 
absorption, these peaks must have been due to impurities 
and the absorption measured at these wavelengths is 
an indication of some of the impurity present.
The large difference between colorimetric and 
gravimetric estimation (see totals Table I) stresses 
the impurity of the product and the non-specificity 
of the method of assay.
STUDY 0E PLACENTAE.
The relationship between the duration of 
pregnancy and Baby's weights are shown on Table III. 
There was no correlation found between the pregnane­
diol excretion, by either method and these results.
Nor was there any correlation between the 
histological appearances of the placentae and the 
pregnanediol assays.
REVIEW OE PREVIOUS CLINICAL EXPERIENCE WHEN THE 
METHOD OF HEHDERSOU ET AL (1949) WAS USED.
The records of 24 gynaecological cases were 
available for study; infrequent or irregular 
menstruction or infertility were the main complaints 
In all cases pregnanediol was estimated by Method II 
Nine of these patients had levels ranging from 
0.7 - 4.5 mg./ 24 hours from the 14th to 28th day 
of the menstrual cycle, and in all cases the 
endometrium showed histological evidence of progest­
erone activity. In 2 other cases, although 
pregnanediol was detected in the urine, the endomet­
rium was of the hypoplastic non-secretory type.
In the remaining patients, evidence of ovarian or 
pituitary dysfunction was detected by other 
endocrine assays, and no pregnanediol was present 
in the urine.
Only 2 abnormally high levels of pregnanediol
excretion were found among 700 patients investigated 
both occurring in hermaphrodite children aged 4
Table 4,
THE KESULTS OF THE ENDOCHIHE IW E S T1 G iiTlQ E 
OF TWO K E iM S lrH ll)i)IT E  C H lL D iiE f.
Case 1. Case 11.
Colorimetric Method 1. 79 24
Estimation of
Pregnanediol Method 2. 51 6,4
Gravimetric Method 1. 130
Estimation of
Pregnanediol Method 2. 29
1% Method 1. 80*7
E at 235 my1* 
lorn. Method 2. - 71.5
17 Ketosteroid 
Excretion 
mgrns/day 45 11
years. The final pregnanediol fraction consisted 
in each case of a brown oily substance instead of 
white crystalline solid. The results are shown 
in Table IV. The ultraviolet absorption spectra 
showed a marked peak with a very high extinction 
value in both cases at 236 mp., thus indicating 
the possible presence of a large quantity of 
unsaturated ketone. Cortisone therapy (50 mg./day 
intramuscularly) reduced the level of excretion 
of this material to zero within 4 days, indicating 
that the substance was probably of adrenal origin. 
Thus false positive pregnanediol excretions were 
found in these cases.
The individual records of 20 cases of habitual 
or threatened abortions were also available for 
close study. Not all cases where low levels of 
pregnanediol were detected, miscarried, and in some 
cases with normal levels the outcome from pregnancy 
was unsatisfactory. Weekly determinations were 
carried out in one patient with a history of 2 
previous miscarriages. She had stilboestrol 
and progesterone therapy during the investigation 
and delivered a living child at term;
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the pregnanediol excretion in this case varied 
markedly from week to week.
In a few cases of pre-eclamptic toxaemia 
wheie an attempt had been made to use the estimation 
as a measure of placental function, marked variation 
in the results obtained rendered this impossible. 
Thus in 2 cases where the patient delivered living 
babies at 34/35 weeks the urinary pregnanediol 
excretion levels were 5*6 and 6.5 mg. respectively.
DISCUSSION.
The work reported here shows clearly that 
the estimation of urinary pregnanediol by the above 
techniques, which were chosen as being the most 
satisfactory available, must be of very doubtful 
clinical value. Considerable variation has been 
shown in the level of excretion of pregnanediol 
in normal pregnancy between individuals and 
possible a small day to day variation in the same 
individuals. A marked variation was apparent 
when comparisons were made between the
two methods of obtaining the purified extract and 
between the two methods of estimating the pregnanediol 
content. There was also a high error variation.
The melting points and absorption spectra of the 
end products together with the difference in values 
obtained by colorimetric and gravimetric estimation 
indicate that much of this variation is due to the 
presence of impurity. This has been proved in the 
past to give fictitiously high results for most of 
the shorter methods for estimating pregnanediol 
based on the procedures of Astwood & Jones (1941) 
and Talbot, Berman, Maclaghan & Wolfe (1941).
In the light of these errors a careful 
re-assessment of. previous experience with these 
methods of assay was undertaken lest any useful 
clinical correlation be overlooked. None was 
found. The variation in the results in cases of 
habitual and threatened abortion and pre-eelamptic 
toxaemia made it impossible for the test to be used 
as a diagnostic aid in cases cited.
Palse positive results for pregnanediol were 
obtained in 2 gynaecological cases in which the
27.
endometrium was of the hypoplastic non-secretory 
type and in 2 cases of hermaphroditism in children. 
These observations are in line with that of Swyer 
(1949) who stated MThe total excretion of pregnane­
diol in the luteal phase of the menstrual cycle was 
so variable that one cannot hope to give indisputable 
evidence of eorpus luteal activity'’.
SUMMARY AED CONCLUSIONS.
The levels of urinary pregnanediol excretion 
in late pregnancy were studied by two methods of 
assay.
In a planned study of the variations in these 
levels, estimations were made on the 24-hour urine 
specimen of each of 10 normal 34-36 week primigravid 
women oh each of three consecutive days. Purified 
extracts from each urine sample were prepared by 
each method and the pregnanediol content estimated 
both gravimetrieally and colorimetrically.
The 4 methods of assay gave widely different 
results which were analysed by the analysis of 
variance.
The difference between the results obtained by the 
two methods and by the gravimetric and colorimetric 
assay were highly significant.
The melting points and the ultraviolet light 
absorption of the purified extracts were also 
investigated and were found not to be those of pure 
pregnanediol.
It was concluded that the impurities present 
in the purified extracts accounted for much of the 
variation in the results obtained and for the high 
level of uncontrollable error.
A review, to determine any clinical value of 
these assays, carried out over several years, did 
not reveal any clear evidence of usefulness which 
might be set against the errors above described.
It was thus concluded that these methods were 
not sufficiently specific, sensitive or accurate 
for the estimation of urinary pregnanediol, and that 
further research upon the method of extraction would 
be necessary before any study of the pregnanediol 
excretion in abnormal pregnancy could be contemplated.
Part B .
ANALYSIS OP THE METHOD FINALLY CHOSEN
FOR ESTIMATING- THE URINARY PREG-NANBIIOL. 
INTRODUCTION.
A new method of estimating pregnanediol was 
reported by Klopper, 'Mtchie & Brown (1955).
Through the courtesy of Dr. Klopper, the details 
of this method were made available to me before 
publication and an experiment, similar in design 
to that previously employed, was undertaken to evaluate 
this new method.
DESIG-N OF EXPERIMENT.
Three consecutive carefully collected 24 hour 
specimens of urine from each of 10 normal patients 
in the 32 - 36th week of pregnancy were examined.
The pregnanediol content was estimated independently 
by myself and a technician, duplicate estimations 
being carried out on the same specimen of urine.
METHOD.
The only major modification to the method of 
Klopper et al (1955) was the omission of the
permanganate wash. Recent work hy Klopper (1955), 
completed after we had begun this investigation, 
indicated that this step is necessary in the case 
of non-pregnant urines and although desirable in 
pregnancy urines, is not essential in the majority 
of cases. (Klopper .1955) .
In 5 cases ( 1 - 5  Table I) duplicate samples 
of urine were taken, each being one twentieth of 
the 24 hour volume; these provided sufficient 
material for the tests for purity on the final 
extract in addition to the normal assay. In the 
other 5 cases (6 - 10 Table I) pregnanediol assays 
only were carried out and a smaller quantity of 
urine, (l/250th) was taken. After acid hydrolysis 
the urine was extracted with toluene and this extract 
washqd first with N-l\TaOH and then with distilled 
water, and evaporated to approximately 10 ml.
This was applied, after cooling to room temperature, 
to the surface of a chromatography column previously 
prepared from 3 g alumina in a tube of 1 cm. diameter. 
The column was washed with 2 5 ml. 0.87° ethanol in 
benzene,' and the pregnanediol fraction then eluted
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with 13 ml. 3% ethanol in benzene. (The volumes 
of solvents used in chromatography have to be slightly 
modified with different batches of alumina). The 
second eluate was evaporated to dryness and the 
residues acetylated with acetyl chloride in benzene,
2 ml. of each. Light petroleum, (b.p. 40° - 60°) 
was then added, and the solution washed with 25 ml.
80% strength aqueous bicarbonate, and twice with 
25 ml. distilled water and chromatography was again 
carried out. The column was similar to that used 
previously but it was prepared in light petroleum 
instead of benzene. The pregnanediol diacetate was 
eluted with 15 ml. of benzene. This was evaporated 
to dryness and approximately 10 mg. sodium sulphite 
was added. The colour was developed by adding 10 ml. 
of concentrated sulphuric acid and allowing the 
solution to stand in a water bath at 25° for 1 hour, 
the absorption of the solution was measured in the 
Spekker Photoelectric Absorptiometer using an Ilford 
Spectrum Violet 601 filter, (transmission maximum 
403 m\x.) .
When the twentieth of the 24-hour specimen was
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extracted, the final products were examined for 
purity by measuring their melting points on a 
Grallencamp (London) stage and their ultraviolet 
absorption spectra both in ethanol and sulphuric 
acid in a Unicam (Cambridge) Quartz Spectrophotometer,
S.P.500.
Recovery experiments were carried out by 
adding 0.2 mg. pure pregnanediol in 0.2 ml ethanol 
to 150 ml. male urine or 10 ml. late pregnancy 
urine, followed by hydrolysis and extraction, as 
previously described. Pour male urines and two 
late pregnancy were studied.
RESULTS.
The melting points of the final acetylated 
products in the case of patients 1 - 5  are shown 
in Table I. The melting points were bi-phasic, but 
only the lower temperatures are shown. The ultraviolet 
absorption was measured in ethanolic solution, and 
after 1 hour in concentrated sulphuric acid at 25° C.
The peaks in all cases were in the same positions as 
those for pure pregnanediol di-acetate but the 
extinction values of these wavelengths were
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EXCRETION OP PREGNANEDIOL IN M S ,  PER 24-HOURS ON THREE. 
CONSECUTIVE DAIS IN NORMAL 32 - 36 WEEK PREGNANCIES
Patients Reading
1
Day
2 3
Sum,
6 Readings
Average
Reading
1 1 39.3 36.6 40.2
2 40.0 35.8 44.0
Sum 79.5 72.4 84.2 236.1 . 3.9.35 . .
2 1 31.6 34.8 38.4
2 27.8 33.8 35.8
Sum 59.4 68.6 74.2 202.2 33.70
3 1 51.5 51.9 53.2
2 51.8 52.8 52.3
Sum 103.3 104.7 105.5 313.5 52.25
4 1 36.3 40.0 37.5
2 36.9 37.5 36.7
Sum 73.2 77.5 74.2 224.9 37.48
5 1 35.6 3 8.2 35.8
2 34.8 36.2 36.6
Sum 70.4 74.4 72.4 217.2 36.20
6 1 44.8 48.0 48.3
2 48.7 46.3 52.1
Sum 93.5 94.3 100 0 4 288.2 48.03
7 1 26.6 29.6 23.0
2 26.8 28.5 23.9
Sum 53.4 58.1 46.9 158.4 26.40
8 1 27.3 25.3 26.8
2 25.3 25.8 26.3
Sum 52.6 51.1 53.1 156.8 26.13
9 1 27.1 27.0 26.9
2 31.3 25.8 26.8
Sum 58.4 52.8 53.7 164.9 27.48
10 1 41.2 41.3 41.9
2 43.2 42.7 39.2
Sum 84*4 84.0 81.1 249.5 41.58
SUM,
20 READINGS. 728.1 737.9 745.7 2211.7
average
HEADING 36.41 36.90 37.29 36.86
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invariably increased (Graph I & II).
The final extract was thus purer than that 
which was obtained by the methods which had been 
previously tested.
The 24-hour pregnanediol excretiohs were
analysed statistically. After averaging the
duplicate readings, the results were set out in
table form, (Table II), where the marginal totals
reveal the main features of the experiment. Using
the analysis of variance the patients differed
significantly, as was expected. The interaction
Patients X days is significant, indicating that
even when allowance is made for the testing error
(deduced from comparison of the readings of the two
observers) the estimated excretion in any particular
patient does not vary from day to day. This
"occasion" variation has an estimated standard
deviation oj 8.5 - 2.1 i.e. 1.8 appears to be random, 
y 2
the lack of significance between day mean square 
suggesting the absence of any appreciable daily 
pattern of variation common to all patients. The 
testing error of a single sample has a standard
Table III.
APALTSIS OP VARIANCE
Source of 
Variation.
Degrees
of.
Freedom
Sum of 
Squares
Mean
Square
Between women 9 4280
XXX
475.6
Between days 2 8 4» 8
ns
Interaction or 
Random error 18 153
XXX
8.5
Residual or 
Testing error 30 62 2.10
Total 39 4503 -
The mean squared difference between women is 
significant on the 0.1% level. The difference 
between days is not significant when compared 
with the interaction mean square which foims 
the appropriate basis for such a test. The 
interaction mean square itself is significant 
on 0.1°/q level when tested against the testing 
error mean square.
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deviation of approximately 1.45* Hence if any 
attempt is made to measure the general level of 
output at any particular phase of pregnancy within 
the period covered by the experiment using only one 
test by one person the error will be the sum of the 
occasion variation and the testing error and will
p
have an estimated standard deviation (1.45 ) +
(1.8 )2 i.e. 2 .30.
DISCUSSION.
In the critical evaluation of this new method 
of assay, some uncertainties need to be discussed.
The specificity of this method, as with the 
older techniques previously studied, depends upon 
the purity of the final extract. Using the melting 
points and ultraviolet absorptions as criteria of 
purity, it has been shown that a final product is 
obtained which is only slightly less pure than a 
specimen of pregnanediol-di-acetate, produced by 
acetylation of a pure sample of pregnanediol 
followed by chromatography and repeated 
recrystalisations from ether.
Recovery experiments when pure pregnanediol 
was added to the urine show that 80-96/ of the 
pregnanediol originally present ih the urine is 
estimated in the final extract. These findings are 
similar to those reported by Klopper et al (1955)•
The- laboratory error of this method was 
determined when the assay was performed on three 
consecutive 24-hour specimens of late pregnancy 
urine. G-ood duplication of the results by 
independent observers shows that the laboratory 
error is low; however with pregnancy urine it is 
necessary to use only a small portion, (1/250), 
of the 24-hour specimen and thus any laboratory 
errors are multiplied by 250 when the 24-hour output 
is estimated. Despite this, the standard deviation 
of the testing error is only 1 .49*
The random errors due to day to day variation 
in laboratory conditions, faulty urine collection, 
etc., have been reduced so far as could be contrived 
in the results reported here: but these known and
unknown sources of variation can never be entirely 
eliminated. The best that can be hoped for is that
the residual error is lower than the changing levels 
which are sought. In this study the standard 
deviation for the residual error was encouragingly 
low 2.3 due in a large measure to co-operation of 
the patients selected. Five were doctors’ wives 
and the other five were nursing sisters, all of 
whom were aware of the need for great care in 
collection complete 24-hour specimens of urine.
The evident superiority of the method of 
Klopper et al (1955), as compared with the previous 
techniques examined, thus provided a means for 
routine clinical investigations. Provided that 
great care is taken at all stages of the assay, 
particularly in the accurate collection of the 
twenty-four hour sample, results of reasonable 
dependency can be expected.
SUMMARY AND CONCLUSIONS.
The method developed by Klopper et al (1955), 
for estimating urinary pregnanediol has been 
investigated in late pregnancy, and the results 
reported here.
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As a planned study of the method and of the 
variations in the daily excretion under known 
conditions, estimations were made on 24-hour 
specimens of each of 10 normal 34-36 week primigravid 
women on each of three consecutive days.
Measurement of the melting points and 
ultraviolet light absorption showed the final extract 
to have a high degree of purity.
The analysis of variance of the results showed 
a marked difference between the amounts of pregnanediol 
excreted by the different patients; but no difference 
between the daily outputs. The testing error of 
the method as estimated from the duplicate results 
of two independent observers was low. The residual 
or ''occasion" error was small enough to justify a 
further study of the test.
This method was thus chosen to study the 
application of this assay in the management of 
early and late pregnancy disorders.
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Part G .
THE RELATIONSHIP BETWEEN MPROGESTATIONAL 
ACTIVITY*1 OP THE BLOOD AHD URINARY PREG- 
NAKEDIOL EXCRETION IN NORMAL PREGNANCY.
Hooker & Porbes (1947) described a technique 
whereby’’progestational activity1 could be measured 
by observing the response of the stromal cells of 
the endometrium of mice to local applications of 
progesterone or extracts containing substances of 
’’progestational activity" Essentially the test 
is carried out by injecting measured micro­
quantities (0.0006 ml. or less) of the fluid under 
test into the uterine horn of a previously 
ovariectomised mouse, leakage of the injected fluid 
being prevented by two ligatures one above and one 
below the injection mass. The characteristic 
response in the endometrial stromal cells, seen 
48 hours after injection, consists of a change 
from stellate or polygonal cell forms to a smooth, 
slightly elongated oval outline; the chromatin 
threads become fine and evenly distributed, and 
the nucleolus is conspicuous.
The minimal dose of progesterone to produce 
this effect in the strain of mice employed by these 
workers was 0.0002 p. g. The authors showed that 
other steroids failed to produce this change and 
concluded that the test was reasonably specific in 
denoting; progestational activity Forbes (1950) 
also produced evidence to show that progestational 
activity could be demonstrated in plasma extracts 
of as little as 1 ml. of blood taken from women 
during the secretory phase of the menstrual cycle.
Hitherto the biological test for progestational 
activity was carried out in rabbits and the amount 
of progesterone necessary to produce positive 
responses precluded the possibility of applying 
this test to the routine study of blood plasma 
levels of progesterone in women. With the Hooker 
& Forbes’ Test available, it was decided to 
determine whether the progestational activity level, 
measured in terms of progesterone, bore any 
relationship to the level of pregnanediol in the 
urine. Preliminary tests, using solutions of 
progesterone in sesame oil, showed that with the
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strain of mice available the sensitivity of the 
test was strictly comparable with that described 
by Hooker & Forbes (1947).
METHOD.
Three consecutive 24 hour specimens of urine 
were collected during the 34th to 36th week from 
each of two patients who subsequently were delivered 
of live babies. Pregnanediol estimations were 
carried out on each of these three specimens in each 
case, and the average daily excretion determined.
On the second day of collection, a specimen of 
citrated blood was obtained. The citrated plasma 
was extracted twice with 10 ml. ether, and then 2 ml. 
sesame oil was shaken up with the ether extract.
The ether was removed by distillation under reduced 
pressure, and 0.0006 ml. of the final solution or 
dilutions thereof were injected into the uterine 
horns of ovariectomised mice. The greatest dilution 
giving a positive response was considered to show 
progestational activity equivalent to 0.0002 u g. 
progesterone, the activity of the plasma then being 
expressed in terms ofu g. progesterone per ml.
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Table 1. THji BIPOD ''PltQGiiBTATiGItA.L ACTl'vTiA" lb bUxuvxAL
BliiGbMiCY.
Final duration Duration at Average 
Case of time of Pregnane-
No. pregnancy Estimation diol
in weeks in weeks excretion
in
mg/2 4 hrs.
Progestational 
activity'An 
ug. Progester­
one /ml.
1 41 34 26.2 3.4 - 8.5
2 38 35 26.6 > 8.5
3 40 33 27.5 3.4 - 8.5
4 40 34 32.2 3.4 - 8.3-
5 39 36 36.5 0.9 - 1.7
6 41 34 37.3 0.2 - 0.9
7 40 34 39.3 0.2 - 0.9
8 41 32 42.1 > 8.5
9 40 35 48.0 0.9 - 1.7
10 40 34 52.0 1.7 - 3.4
No attempt was made to hydrolyse the plasma extract 
and therefore the recorded values are an expression 
of free progestational activity, and dLO not include 
any combined or "bound” progestins.
The results in the ten cases are set out in 
Table I. -
The results show that whereas positive 
responses were obtained by the Hooker Forbes (1947) 
technique in all ten cases examined, there was no 
correlation between the level of response and the 
level of pregnanediol excretion. It seemed 
improbable that this technique would give an index 
of placental activity more reliable than the 
pregnanediol assay, and no further work using 
this technique was carried out.
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SECTION II.
THE PREGNANEDIOL EXCRETION IN NORMAL 
PREGNANCY AND IN THE PUERPERIUM.
The excretion of pregnanediol during pregnancy 
has been studied by many workers and the results 
show a general trend of high level excretion in the 
last three months of pregnancy with a fall to zero 
levels soom after delivery. Thus Browne, Henry & 
Venning (1937) estimating sodium pregnanediol 
glycuronide, obtained values of 40 mg./24 hours 
at the 21st week, peak values of 73 to 80 mg./24 
hours at the 32nd week and showed that there was a 
fall just before delivery. Estimating ’'free 
pregnanediol” by precipitation techniques values of 
between 36 and 120 mg./24 hours were obtained in the 
later weeks of pregnancy by Davis & Eugo (1947), 
Guterman (1944) (1945), Jones, Delfs & Straun (1944) 
and Michie (1953) • Lower values were obtained by 
de Watteville (1951) and Trolle (1955). The 
pattern of excretion immediately preceding 
parturition is not clear. Stover & Pratt (1939) 
and Hain (1941) found that the excretion was
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maintained until the onset of labour. In contrast, 
a fall in excretion rate was demonstrated by several 
workers (Pratt, Simmonet & Robson, 1940, Lyon, 1940 
and Maunsey, 1950).
Other workers were unable to demonstrate a 
characteristic excretion pattern for the period 
immediately preceding delivery (Venning, 1948, 
Bradshaw & Jessop, 1953> and Trolle, 1955)*
There was general agreement that pregnanediol falls 
rapidly after delivery and reaches low levels in 
3 to 6 days.
Variations in the techniques of assay are in
part clearly the cause of the lack of uniformity in
the results reported by the above workers and 
accordingly it was necessary to study the pattern 
of pregnanediol excretion throughout normal 
pregnancy and the early puerperium by the method 
of Klopper et al (1954).
PLAh OP INVESTIGATION.
The following aspects of the pregnanediol
excretion in normal pregnancy were studied:-
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Fig. I.A. MEAN ESTIMATES OP URINARY PREGNANEDIOL
EXCRETION FOR EACH WEEK OP PREGNANCY.
Fig. I.B. STANDARD DEVIATIONS CALCULATED FOR
EACH WEEK OF PREGNANCY.
______ Range of excretion * 2 x S.D....
_______ Mean estimates...
l) The pregnanediol excretion from the 10th week 
of pregnancy till the onset of labour.
Pregnanediol estimations were made on the urines 
of 24 women at intervals varying from 1 to 3 weeks 
throughout the course of pregnancy. They were a 
highly selected group of patients, being either the 
wives of doctors or former nursing sisters of the 
hospital. They all delivered living babies at the 
38th to 42nd week of pregnancy and in each case the 
birth weight of the baby and the weight of the 
placentae was noted.
2) The pregnanediol excretion after parturition. 
Four hourly estimations were made in five cases 
during the 24 hours after delivery. All specimens 
were collected by catheter to prevent contamination 
with blood. In 9 cases pregnanediol determinations 
were made at Hintervals” until the. 9th or 10th day 
after delivery.
RESULTS.
The mean estimated of the urinary pregnanediol 
excretion during each week of pregnancy are shown on 
Fig.I. The range of excretion throughout normal
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Pig. II. THE PREGNANEDIOL EXCRETION IN
normal p r e g n a n c y calculated
PROM THE DURATION OP TIME 
BEPORE DELIVERY.
  Range of pregnanediol excretion.
------ Average excretion.
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Pig. III. THE PREGNANEDIOL EXCRETION, IN 
5 NORMAL PREGNANT WOMEN, DURING 
THE 6 WEEKS BEPORE DELIVERY.
In these cases there was 
a fall in excretion before 
delivery.
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pregnancy is shown on Pig. II; it is a scatter 
diagram of all the readings obtained in the 24 cases, 
the mean and standard deviations being calculated 
for each week of pregnancy. Because the duration 
of pregnancy varied from 38 to 42 weeks the points 
on the diagram are plotted according to the levels 
of pregnanediol and the duration of time before 
delivery. It will be noted that the range calculated 
from the mean + 2 S D varies from 2 to 15 mg./24 hours 
at the.10th week to 27 to 69 mg./24 hours at the 37th 
week the values falling to 20 to 64 mg./24 hours at 
the 40th week of pregnancy.
The trend of pregnanediol excretion in five 
eases where weekly determinations were made throughout 
the course of pregnancy is shown in Pig. III. 
Variations in the weekly excretion, in the same 
patient, occur .‘but where a fall in the excretion is 
noted it is seldom more than 10 mg./24 hours and it 
is never below the normal pregnancy range. In the 
five cases shown in Pig. Ill the pregnanediol 
excretion fell during the 2 to 4 weeks before delivery.
Pig. IV shows the pregnanediol excretion in 4
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ffig. IV. THE PREGNANEDIOL EXCRETION, IE 
5 NORMAL PREGNANT WOMEN, DURING 
THE 6 WEEKS BEEORE DELITERY.
In these cases a fall 
before delivery was not 
detected.
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.gig. V . THE DAILY PREG-NANEDIOL EXCRETION 
IN A NORMAL PREGNANT WOMEN.
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cases where a fall before the onset of labour was 
not detected. In one of these cases a rise in 
excretion was actually detected during the 2 weeks 
before delivery.
When daily estimations were made in 4 cases a 
constant excretion was maintained for 10 days in 3 
cases and in one patient a rise occurred five days 
before delivery, Fig. V.
Fig. VI shows the pregnanediol excretion before 
and after delivery in 9 cases, it will be noted that 
there is a fairly constant daily excretion before 
delivery in all cases. During the first 24 hours 
after delivery the excretion is maintained at a high 
level. In 5 cases it is less than 6 mg./24 hours 
lower than the excretion before delivery. A rapid 
fall occurs during the next 10 days and levels of 
2 to 4 mg./24 hours are found on the 10th day of 
the puerperium.
When four hourly estimations were made in five 
patients immediately after delivery, a high level of 
excretion was found in the first four hours 
( 5 - 1 7  mg./ 4 hours). There was then a rapid
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Fig. YII. THE 4 HOURLY PREGNANEDIOL
EXCRETION IN 5 NORMAL PREGNANT 
WOMEN FOR 24 HOURS AFTER 
DELIVERY.
fall to levels of 2 to 4 mg./ 4 hours and in the 
last 12 hours the excretion remained fairly constant 
(Fig. VII).
DISCUSSION.
The range of pregnanediol excretion in normal 
pregnaney for the method of Klopper et'al (1954) was 
studied by making regular estimations at regular 
"intervals” throughout the course of pregnancy in 24 
intelligent women. The range is lower than that 
obtained, by other workers, using precipitation 
techniques, G-uterman (1954), Davis & Fugo (1947) 
and JMtchie (1953) • It is higher than that obtained 
by other chromatographic techniques, de Watteville 
(1951) and Trolle (1955)• This is understandable 
as it has already been shown that the former
techniques estimate an impure form of pregnanediol
and in the latter technique pregnanediol is purified 
by leaching with cold solvents and this may remove 
some of the extracted pregnanediol (Klopper et al (1954)).
The pregnanediol excretion in pregnancy reaches a
peak level at the 37th week and there is usually a fall
in the test two or three weeks preceding delivery
(Fig. II); but the results obtained in the study 
of individual cases show that, of the 17 patients who 
were under observation until the onset of labour 
13 had a fall in the excretion during the 36 - 38th 
week of pregnancy', excretion was maintained at a high 
level in the other 4 cases (Fig. IV).
When daily determinations were made in 9 cases 
the excretion level did not fall before delivery 
(Fig. V & VI). These results confirm the observations 
of Stover & Pratt (1939) and Hain (1941).
The pregnanediol excretion during the 24 hours 
following delivery was found to be high. All .the 
patients were catheterised immediately after the 
placenta was expelled thus the pregnanediol excreted 
during that period may have been present in the blood 
at the time of delivery. In 5 of the 9 cases the 
excretion was less than 6 mg./24 hours lower than 
the level before the onset of labour. In case I 
(Fig. VI) , although the patient was catheterised 
after completion of the third stage of labour the 
4 hourly collection of urine was not organised for 
5i hours during which time the patient had passed
urine. This may account for the low value obtained 
in this case in the 24 hours after delivery 
(15 mg./24 hours). Bradshaw & Jessop (1953) 
obtained values ranging from 5 to 28 mg./24 hours 
during the first 24 hours after delivery and 
1 - 2.7.mg./24 hours on the 33rd day. Trolle (1955) 
found that the excretion during the first 24 hours 
in 4 cases was the same as that before delivery 
(15 - 30 mg./24 hours) but he obtained a fall to 
nil in the course of the next 3 - 6  days.
A gradual fall in excretion was obtained 
during the puerperium by the method of Klopper et al 
(1954), levels of 2 - 4 mg. being found on the 10th 
day after parturition. When four hourly excretion 
rates were studied, excretion immediately after 
delivery was high ( 5 - 1 7  mg./24 hours) and then 
there was a gradual drop, the level being maintained 
for the 12 to 24 hours after delivery (Pig. VII
SUMMARY AND CONCLUSIONS.
The range of pregnanediol excretion throughout 
normal pregnancy was studied using the method of 
Klopper et al (1954). The range is wide. It varies
from 2 - 1 5  mg./24 hours at the 10th week to 
27 - 68 mg./24 hours at the 37th week. In most 
cases there is a fall in excretion in the weeks 
preceeding labour but in 4 of the 17 patients 
studied here the excretion was maintained.
When daily determinations were made for 10 
days preceeding the onset of labour little variation 
was found in 3 patients but one patient had a 
10 mg./24 hours rise in excretion.
After delivery the pregnanediol excretion was 
maintained at a high level for 24 hours and then 
there was a gradual fall to a level of 2 - 4 mg./24 hours 
on the 10th day after parturition. More than -§• of 
the pregnanediol excreted during the 24 hours after 
delivery appears in the urine in the first 4 hours.
CONCLUSION
The pregnanediol excretion in normal pregnancy 
for the method of Klopper et al (1954) is now 
established. There is no specific variation 
characteristic of the approach of labour in the daily 
excretion but in the majority of cases the excretion
reaches a peak level at about the 36 to 38th week 
of pregnancy and then there is a gradual fall before 
delivery.
Luring the first 24 hours after delivery the 
excretion is only slightly lower than the excretion 
before delivery, the major part of this excretion 
occuring in the first four hours after delivery.
SECTION III.
THE PREGNANEDIOL EXCRETION IN THREATENED
AND IN RECURRENT ABORTION. AND IN 
HYDATIDIEORM MOLE.
Among the many factors which are alleged to play 
a part in the aetiology of spontaneous abortion 
hormonal imbalance occupies an important place;
There is as yet little knowledge and few measures 
of what constitutes hormonal balance. This section 
is concerned with only one aspect of the problem, the 
excretion of pregnanediol. Opinion as to the value 
of this assay differ; there are some who have found 
the pregnanediol excretion to be a reliable guide 
by demonstrating subnormal values preceding abortion 
(Venning 1937, Cope 1940, Guterman 194 7, Bishop 1948, 
Guterman & Tulsky 1949, & Borglin 1956); whereas 
others maintain that normal values do not exclude 
the possibility of impending abortion, and doubt the 
significance of low values, (Hamblen, Cuyler &
Baptist 1942, Swyer 1949, Plotz & Darup 1950,
Zander 1951 and Swyer & Daly 1953)*
Despite these uncertainties, progesterone has 
been used in the prevention of abortion (Bender 1948, 
Guterman 1953, Bishop, Richards & Doll 1950) and 
Smith & Smith (1948), considering that the metabolism 
of oestrogen and progesterone were interdependent, 
advised _the administration of oestrogen and claimed 
an increase in the pregnanediol excretion when 
stilboestrol was administered during pregnancy.
Similar findings were reported by Davis & Rugo (1947 
and Sommerville, Marrian & Clayton (1949)•
Guterman (1953) maintained that when progesterone 
was injected intramuscularly in cases of threatened 
abortion, abortion ensued if under 20$ of the 
progesterone was converted into pregnanediol but if 
the conversion rate was about 20$, the pregnancy 
continued undisturbed.
Most workers who have assessed the progesterone 
metabolism in early abnormal pregnancy have used the 
methods for extracting and purifying pregnanediol 
which according to Marrian (1954) are not sufficiently 
sensitive, specific or accurate for the small amounts 
of pregnanediol found in early pregnancy urine.
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The investigation detailed here is a reassessment 
of the value of the pre-gnanediol assay in the management 
of cases of threatened and recurrent abortion using 
the more reliable method of Klopper et al (1954)•
It is divided into 4 sections
1) Tire pregnanediol excretion in cases of threatened 
and recurrent abortion where no specific form of 
therapy was used;
2) The pregnanediol excretion in cases of recurrent
abortion when stilboestrol therapy was used:
3) The conversion rate of exogenous progesterone
in 15 cases of threatened abortion; and
4) The pregnanediol excretion in 5 cases of
Hydatidiform mole.
TEE PREG-NAKED101 EXCRETION IN THREATENED ABORTION.
Patients with a history of vaginal bleeding and 
abdominal pain in early pregnancy had a twenty four 
hour specimen of urine collected on admission to 
hospital. Cases in which abortion occurred within 
3 days of admission were not included in the series, 
as they were assumed to have been inevitable dr 
incomplete when first seen. In a series of 70 primary
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Fig. I. THE PREGNANEDIOL EXCRETION IN 61 CASES 
OE PRIMARY THREATENED ABORTION
A. *** Live births (29 cases)
B. • •• Abortions (32 Eases)
Normal pregnancy range.
Average readings for normal pregnancy.
threatened abortions, single pregnanediol estimations 
were made in 61 cases the remaining 9 cases having 
estimations carried out at weekly intervals. The 
duration of pregnancy at the time when the patients 
threatened to abort varied from 8 to 20 weeks. The 
results are shown on Eig. I. Of the 61 patients, 29 
delivered live babies and 32 aborted. Before the 
12th week of pregnancy there was no difference between 
the results obtained in the live birth and the aborted 
group. After that period 7 (30$) of the results 
obtained in the live birth group were above the average 
values obtained in normal pregnancy, whereas in the 
aborted group only 2 (10$) were above it; moreover 
in the latter group 5 (26$) of the readings were below 
the limits of the normal pregnancy range as compared 
with the live birth group where all the values were 
within the normal pregnancy range.
Pregnanediol estimations were made at weekly 
intervals in 9 cases; of these 5 delivered live 
babies (29 observations)and 4 aborted (17 observations) 
The results for each week of pregnancy are shown on 
Eig. Ila and lib. which are scatter diagrams of all
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Pig. II. THE PREGNANEDIOL EXCRETION IN 9 CASES 
OE PRIMARY THREATENED ABORTION.
A.xxx Live Births (5 cases)
B .•••Abortions (4 cases)
Normal Pregnancy Range
  Average readings for Normal Pregnancy
Average readings for cases of 
Threatened abortions.
Table J .TKS BhiGNaNEulOL aICHETION IN 9 GASES OF FNIMAHr
. THREATENED ABOHTION.
Threatened abortion (live birth) 5 cases
hosp­
ital Weeks of* pregnancy
No. 8 9 10 11 12 13 14 15 16
8284 6.9 5.0 7.2 8.2 8.0 7.4 10.2 14.0
10900 5.2 5.5 5.8 7.2 9.2
876 10.8 10.0 13.2 16.0 17.0
12558 2.4 5.6 5.0 5.3 6.2
36055 5.8 5.7 5.7 15.0 15.1 11.3
Average
readings 6.9 3.7 7.2 7.7 18.9 10.5 12.1 10.9
Threatened abortion (aborted) 4 cases
Hosp­
ital
Weeks of pregnancy
No. 8 9 10 11 12 13 14 15 16 17
13876 6.9 5.1 4.5 4.9
1102 9.8 12.6 11.5 9.2 6.5
2243 3.3 3.7 4* 4 5.2 4.9
9758 7.3 7.9 9.2 8.2
Average
readings 7.3 8.9 8.4 7.6 6.2 5.4 4.9
74.
the readings obtained in these 2 groups of patients.
The values obtained for the pregnanediol excretion 
are similar to those obtained when only single 
estimations were made. When, however the trend in 
individual cases is studied there is some evidence that 
declining results indicate that abortion is likely, 
and rising levels that the pregnancy will continue.
These changes ’. are more marked after the 12th week by 
which time careful clinical examination should give as 
much information as the hormonal assay. Nevertheless, 
the trend after the 12th week might on occasion be of 
value in adding weight to a clinical judgement.
THE PREGNANEDIOL EXCRETION IN RECURRENT ABORTION.
This group of patients received no specific 
form of treatment during this pregnancy. They had a' 
history of 2 or more abortions in previous pregnancies. 
There were 13 patients in the series, 8 delivered live 
babies and 5 aborted. They were kept under observation 
throughout the course of pregnancy and urine was 
collected at daily or weekly intervals.
The results of the weekly pregnanediol estimations 
are shown on Big. Ill a and b, which are scatter
75.
13.A .
20
10
„ — *" x*
2012 16 
Weeks of pregnancy
20
Weeks of pregnancy
Fig. III. THE PREGNANEDIOL EXCRETION Iff 13 CASES 
OE RECURRENT ABORTION WHEN NO SPECIFIC 
. FORM OF THERAPY WAS USED IN THE NEXT 
PREGNANCY.
A. xxx Live births (8 cases)
B. * • * Abortions (5 cases)
■—.. Normal pregnancy range.
-------Average readings for normal pregnancy.
------  Average readings for recurrent
abortions.
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diagrams of the results obtained in the 8 patients 
who delivered live babies and in the 5 who aborted. 
Table II shows the individual results for each patient 
and the average readings for each group. The 
results are similar to those obtained in the live 
birth groups and aborted group of threatened abortions 
All the readings in the live birth group are within 
the normal pregnancy range and the average readings 
rise after the 12th week of pregnancy to above the 
normal pregnancy average. In the aborted group 7 
results lie outside the lower limit of the normal 
range and the average readings show a fall after 
the 12th week of pregnancy.
The results in this group are similar to those 
in the group of primary abortions. Values below 
the normal range were associated with abortions, 
values below the average but still within the normal 
range did not appear to have any clear prognostic 
value, and values within the normal range but above 
the average were usually associated with continuing 
pregnancy.
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A.
B.
THE PREGNANEDIOL EXCRETION.IN CASES 
OE RECURRENT ABORTION WHO DELIVERED 
LIVE BABIES IN THE NEXT PREGNANCY.
No specific therapy (8 cases)
Stilboestrol therapy (6 cases)
The shaded areas show the limits 
of the lowest and highest 
readings obtained.
Normal Pregnancy Range
Average readings for normal pregnancy
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Table 4 THE DAI IX PiiECkANEDIGL EXCNETION IK 6 CASTS ON 
xtilJUilTlNT XBOitTION VViiO i)E1 .T vTk pi ) LIVE BABIES
No Specific I‘herapy Stilboestrol Therapy
Hospital
Number 127 4755 961 6465 5080 65
Number
of
Abortions 3 2 6 3 3 3
Week of 
Pregnancy 13th 6th 10th 12 th 12 th 11th
Daily
Pregnane­
diol
Excretion
5*8_
5.9
5.7
5.0
5.0
1.5 5jJL
2.6
3?T~ 3.6
3.0 3.5
1.1 4.4 
3.5
1.8 5.1
16.3 
18.0 
17 . T
15.7 
15.0
18.8 
20.0
6.7
6.T^
6.1
6.5
5.8
6.8
12.8
n . r -
13.6
12.0
11.6
11.6
12.4
Week of 
Pregnancy 14th 7 th 11th 13 th 13 th 12 th
Daily
Pregnane­
diol
Excretion
6.6
6.9 
6.6
6.9
2.4
3.3
4.5
3.3
2.9
6.7
4.7 
6.0
7.8
5.9
4.5
6.5
5.9
19.9 
20.6 
19.4 
20.0
15.9
15.8
6.8 
8.0 
7.2 
9.0
13.0
12.8
12.0
13.2
12.0
Week of 
Pregnancy 8th 12th 14th 14th 13th
Daily
Pregnane­
diol
Excretion
5.7
5.8
5.8
6.5 
6.0
16.0
17.5
18.7
10.6 11.6
indicates when the stilboestrol therapy was 
commenced
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2) THE PREGNANEDIOL EXCRETION WHEN STILBOESTROL 
THERAPY WAS USEE IN THE TREATMENT OP 7 PATIENTS 
WITH A HISTORY OP RECURRENT ABORTION.
Stilboestrol in increasing doses was administered 
to 7 patients with a history of 2 or more abortions 
in previous pregnancies. The initial dose was 30 mg. 
daily until the 16th week of pregnancy when it was 
increased by 5 mg. daily at weekly intervals until the 
36th week. Six patients delivered living babies at 
or.near term and one patient aborted at the 24th week 
of pregnancy.
The daily pregnanediol excretion in 2 patients 
who were treated with stilboestrol and in 4 of the 
untreated group are shown on Table IV. The daily 
excretion in both cases was constant and the stilboestrol 
treatment neither increased nor decreased the pregnanediol 
excretion. The results of the weekly determinations 
are shown on Table III where this is again demohstrated.
In Pig. IV. a and b the mean values and the range of 
excretion are plotted against the mean range of normal 
pregnancy. The range in the recurrent abortion group 
is represented by the highest and lowest values obtained
83*
for each week of pregnancy. The range in "both groups 
lies between the normal pregnancy range and that 
obtained in the stilboestrol-treated group is neither 
higher nor lower than in the untreated group.
The pregnanediol excretion in the patient who 
aborted at the 24th week of pregnancy is shown on 
Table III. There was a rise till the 20th week when 
a slight fall occurred, the excretion rate being 
15*5 mg./24 hours when the patient aborted.
3) THE CONVERSION OF EXOGENOUS PROGESTERONE IN 
THREATENED ABORTION.
Fifteen patients between the 9th and 20th week 
of pregnancy were admitted with a history of vaginal 
bleeding and abdominal pain and had pregnanediol assays 
made on 3 consecutive days after admission. On the 
4th day 90 - 100 mg. of accurately weighed progesterone 
in 2 ml. sesame oil was injected intramuscularly.
The percentage of the progesterone excreted as 
pregnanediol was then calculated from the pregnanediol 
excretion during the next 3 "to 4 days.
The progesterone conversion in non-pregnant states
Table 5. THE PROGESTERONE RECOVERY' IN 15 CASES 
01- THREATENED ABORTION.
Duration LL'VE BIRTHS Duration ABORTION
of
Pregnancy
Recovery Pregnane­
diol
Excretion
before
injection
 ^ Recovery 
Pregnancy
%
Pregnane­
diol
Excretion
before
injection
12 weeks 2.4 3.5 13 Nil 10.7
11 7.0 10.8 16 5.8 9.0
t14 7.0 17.0 20 6.3 10.9
16 11.6 14.4 11 6.4 7.3
18 26.0 7.0 16 8.6 5.0
17 27.0 9.0 13 10.9 3.3
-13 30.0 7.5 10 17 2.5
-
9 29 4.0
Average 15^ o 1<$
85.
was found by injecting the same amount in the 
proliferative and in the secretory phase of a menstrual 
cycle. The recovery was 9$ in the proliferative phase 
and 11$ in the secretory phase. These results agreed 
with those of Xlopper & Mitchie (1955) and the 
experiment was not repeated.
In the threatened abortion group of 15 patients 
8 aborted and 7 retained the pregnancy (Table V). The 
conversion rate in the aborted group varied from zero $ 
to 29$ and in the live birth group from 2.4$ to 30$.
The amount of progesterone converted bore no relationship 
to the urinary pregnanediol level nor the duration of 
pregnancy at the time of the injection. The conversion 
rate was not lower in the aborted group than in the other. 
Thus the progesterone conversion test was of no value 
in determining the outcome from pregnancy in this small 
series of cases.
4) THE URINARY PREGNANEDIOL EXCRETION IN 5 CASES OP 
HYP ATIEIE OHM MOLE.
These patients came under observation in the 
course of the investigation into the pregnanediol 
excretion in cases of threatened abortion. They were
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Table 6. TiiE HMJMINQiiDIOL M.CEETION IK 3 CASKS OP
fflDATIDIFOKM MOLS.
Before 3 days 7 days 28 days 6 weeks 10 weeks 
operation after after after after after
operation operation operation operation operation
1 26 23 17.0 ‘ 12.8 3.2 0.7
Before 1 day 2 days 7 days 3 weeks 
operation after after after after
operation operation operation operation
2 6.6 2.8 2.8 2.0 1.3
3 8.8 7.8 3.4 3.2 1.6
4 16.2 10.8 7.8 0.73
5 3.2 2.2 0.9 0.73
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all from 14 to 18 weeks pregnant and in all cases the 
Ascheim-Zondek test was positive in high dilution.
The results of the pregnanediol excretion are shown 
on Table VI. Case I is the most interesting; she 
was 14 weeks pregnant and the size of the uterus 
corresponded to a pregnancy of 20 weeks. The 
Ascheim-Zondek test was positive in a 1 in 1000 
dilution. The ovaries were enlarged to 4 times the 
normal size by large theca-lutein cysts. The 
pregnanediol excretion was 26 mg./24 hours before 
evacuation of the mole and 23 mg./24 hours the next 
day, 17 mg. 7 days later, 12.8 mg. after 28 days,
3.2 mg. after 6 weeks and 0.7 mg. after 10 weeks.
The gradual wall in the pregnanediol excretion was 
roughly parallel to the reduction in the size of the 
ovaries which were palpably enlarged to twice normal 
size on vaginal examination 28 days after the operation, 
and were only slightly enlarged 4 weeks later.
In Case 4 the ovaries were enlarged to about 5 
times normal size by theca-lutein cysts and the 
pregnanediol excretion was 17 mg./24 hours. The mole 
was removed by abdominal hysterectomy and about 75$ 
of the ovaries, which were enlarged by theca-lutein cysts,
were removed at the same time. Thus the regression 
of the pregnanediol excretion was not so marked in 
this case.
In the other 3 cases no palpable enlargement 
of the ovaries was noted. The pregnanediol excretion 
before evacuation of the uterus varied from 8.8 - 
2.4- mg./24 hours and after evacuation it gradually 
fell to normal levels.
DISCUSSION.
The pregnanediol excretion in 70 cases of 
primary threatened abortion was studied. Before the 
12th week of pregnancy the results obtained did not 
give any indication of the final outcome of the 
pregnancy in the majority of the cases. After the 
12th week significantly lower results were obtained in 
the group where abortion occurred. When the results 
obtained in the individual cases were studied it was 
found that in cases where excretion fell, the patient 
was more likely to abort than in cases where a normal 
level of excretion was maintained. However in 3 cases 
where abortion occurred the excretion level was 
maintained (Cables I and II) .
The bleeding in threatened abortion |s due to 
haemorrhage into the chorio-decidual space. This may- 
upset the nutrition of the trophoblast and cause foetal 
death but the progesterone production of the trophoblast 
will only cease when the damage is sufficient to cause 
degeneration of large areas of placenta. The cases 
investigated here show that it is difficult to diagnose 
pi acental degeneration, before the 12th week of pregnancy, 
by the pregnanediol excretion because the range of 
excretion in normal pregnancy is so wide that it is 
difficult to detect abnormal variations. Moreover 
plaeental degeneration is not the only cause of abortion 
in early pregnancy. The foetus may die from some 
other cause, e.g. congenital defect and the placenta 
may still survive.
When the daily or the weekly pregnanediol 
excretion was determined in 6 patients treated with 
stilboestrol who had a history of abortions in previous 
pregnancies, neither an increase nor a fall in 
excretion was noted. The range of excretion compared 
favourably with that found in normal pregnancy (fig* III) 
The dosage of stilboestrol used was similar to that
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recommended by Smith & Smith (1948) who demonstrated 
that stilboestrol increased the pregnanediol excretion 
during pregnancy. Sommerville, Marrian & Kellar (1948) 
found that there was a fall in excretion during the 
administration of 50 mg. of stilboestrol orally.
The findings in the :small series of cases followed 
here confirm the work of Michie (1955) who could not 
demonstrate a rise nor a fall after the oral 
administration of stilboestrol.
The management of cases of recurrent, abortion 
have long aroused controversy. In 8 patients who 
received no specific form of therapy and where the 
outcome of the pregnancy was successful, wide 
variation in the pregnanediol excretion, between 
patients, occurred. These were more marked after 
the 12th week of pregnancy (Fig. lib).
- Patients with low levels of excretion had as 
successful an outcome from pregnancy as those with high 
levels and Bevis (1951) and Swyer & Daly (1953) stressed 
the part played by psychotherapy in the management of 
these cases. King (1953) summarised the results 
obtained by 14 authors who used a variety of treatments
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and came to the conclusion that the success rate was 
not altered hy hormone replacement therapy.
When large doses of progesterone (90 to 100 mg.) 
were injected into patients threatening to abort, the 
amount recovered did not depend onthe outcome of the 
pregnancy. Venning & Browne (1940) and Sommerville & 
Marrian (1950) observed that there was a higher 
conversion of progesterone to pregnanediol in pregnancy 
than in the non-pregnant state. G-uterman (1953)
;showed that in cases of threatened abortion the 
conversion was lowere where abortion occurred than were 
the pregnancy continued. Borth (1954) confirm this 
but Hobson & G-ornall (1951) found this test to be of 
little value. Klopper & Michie (1955) obtained a 
conversion rate of about 16$ in men, pregnant and 
non-pregnant women when a single injection of 50 mg. 
of progesterone was given. The conversion rate in 
the present series was 15$ in the live birth group and 
10$ in the group which aborted. The range of values 
obtained was 2.4$ to 30$ in the latter group and zero $ 
to 29$ in the former. Thus the conversion rate in 
this series varied considerably; it was not influenced
by the outcome of the pregnancy, the initial 
pregnanediol excretion nor the duration of pregnancy.
The high level of pregnanediol excretion over 
a six weekly period after evacuation of a hydatidiform 
mole deserves special mention. The large theca-lutein 
cysts of the ovaries must have been responsible for 
the production of progesterone in this case. In the 
other cases where the ovaries were not enlarged the 
pregnanediol excretion before evacuation of the uterus 
varied from 2.8 to 7*8 mg./24 hours and there was a rapid 
return to normal levels after evacuation. Plotz &
Darup (1950) reported the continued excretion of 
pregnanediol in large quantities for 20 days after 
evacuation of a hydatidiform mole, but they did not 
associate it with theca-lutein cysts of the ovaries.
SUMMARY.
This investigation was undertaken to assess the 
value of the urinary pregnanediol assay in the 
management of cases of threatened and recurrent abortion. 
The chromatographic method of Klopper et al (1954) 
was used in the extraction and purification of the 
pregnanediol.
The assay was found to he of very little value 
in determining the outcome of pregnancy in cases of 
threatened abortion before the 12th week of pregnancy. 
After the 12th week a lower level of excretion was 
found in the cases where abortion occurred than in 
the cases where the pregnancy continued.
In 8 patients with a history of recurrent 
abortions in previous pregnancies who received no 
specific form of therapy in the next pregnancy and 
who delivered live babies, the pregnanediol excretion 
varied from 5 to 15 mg./24 hours at the 12th week of 
pregnancy. The range of excretion was within the 
normal pregnancy range.
When stilboestrol was used in the treatment of 
7 patients with a history of recurrent abortion the 
range of the pregnanediol excretion was again within 
the normal pregnancy range and neither an increase nor 
a decrease in the pregnanediol excretion was noted.
One of the patients aborted at the 24th week of 
pregnancy and a falling excretion was noted before 
abortion occurred.
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When one injection of (90 - 100 mg.) progesterone 
was given to 15 patients with a history of threatened 
abortion the amount recovered as pregnanediol was not 
related to the outcome of the pregnancy, the duration 
of pregnancy or the initial pregnanediol excretion.
In one case of hydatidiform mole where large 
theca-lutein cysts of the ovaries were present the 
pregnanediol excretion was abnormally high (26 mg./
24 hours) for the duration of pregnancy and it 
remained high after evacuation of the mole, returning 
to normal limits when the ovarian enlargement had 
subsided 6 weeks later. In 3 cases where there was 
no ovarian enlargement the pregnanediol excretion was 
lower and normal values were found 2 to 4 weeks after 
evacuation of the moles.
CONCLUSION.
It may be concluded that the estimation of the 
urinary pregnanediol excretion in the early months 
of abnormal pregnancy is seldom helpful because in 
normal pregnancy the excretion varies over such wide 
limits. There is a trend however which suggests that 
after the 12th week of pregnancy an excretion level 
below the normal average for the period of gestation
carries a somewhat worse prognosis than one above the 
normal average.
In the small series of cases of recurrent abortion, 
detailed here, hormone replacement therapy with 
stilboestrol did not appear to increase or decrease 
the pregnanediol excretion.
The conversion rate of progesterone to pregnanediol 
in 15 cases of threatened abortion was not influenced 
by the duration of pregnancy, the initial pregnanediol 
excretion nor the outcome of the pregnancy.
An abnormally high level of excretion in early 
pregnancy may indicate the presence of a hydatidiform 
mole and theca-lutein cysts of the ovaries.
SECTION IV.
THE PREGNANEDIOL EXCRETION IN TOXAEMIA OE PREGNANCY 
AND ESSENTIAL HYPERTENSION.
INTRODUCTION.
The stillbirth and neonatal mortality from 
toxaemia of pregnancy ranges from 5$ to 30$ and it 
is higher in the severe than in the mild and moderate 
cases (Dieckman 1952) . Induction of labour or 
Caesarean section, often performed before term in 
the severe cases of toxaemia, for the benefit of the 
mother results in the birth of premature infants. 
According to Cross (1952) 18$ of the premature babies 
which die are delivered by toxaemic mothers. It is 
likely that the death of some of these babies is due 
to placental insufficiency causing malnutrition in 
utero.
The pregnanediol excretion has been used as an 
idex of placental efficiency, and according to de 
Watteville (1951) and Richli (1953) the foetal prognosis 
is poor if the pregnanediol levels are low. On the 
other hand Trolle (1955) showed that a low pregnanediol 
excretion was not always indicative of poor foetal 
prognosis. Other workers were unable to establish a
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relationship between low pregnanediol excretion and 
the severity of the toxaemia (Yenning, Henry and 
Browne, 1938; Hain, 1940 and Ghandhuri et al 1953).
This investigation was undertaken to establish 
the value of the pregnanediol assay in the management 
of cases of toxaemia and essential hypertension. 
Regular pregnanediol estimations were performed on 
a number of these cases and they were kept under 
observation until delivery, when the type of delivery 
and the duration and character of the labour were 
noted. The weight and condition of the baby and 
the weight, macroscopic and histological appearance 
of the placenta were also recorded.
Patients who came under observation during 
this investigation were referred for pregnanediol 
assays by the hospital staff on account of mild, 
moderate or severe toxaemic signs, or essential 
hypertension in early pregnancy. In some cases the 
investigation was undertaken because the uterine 
growth was less than was expected for the duration of 
ammenorrhoea, although the signs and symptons of 
toxaemia were very mild and improved after admission
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to hospital for treatment.
The cases followed during the course of this 
investigation have heen subdivided into:-
A. Toxaemia of pregnancy.
B. Essential Hypertension in pregnancy.
C. Stillbirths and Neonatal deaths associated 
with toxaemia or Essential Hypertension.
D. Pregnancy associated with chronic renal 
disease.
RESULTS.
A. THE PREGNANEDIOL EXCRETION IN TOXAEMIA OP
PREGNANCY.
The cases in this group all had living babies 
which survived. A subdivision is made into:-
1) The less severe cases which responded to treatment 
and were not delivered until after the 37th week of 
pregnancy.
2) The severe and fulminating cases which did not 
respond to treatment and which were all delivered 
between the 34th and 36th week of pregnancy, except 
one case which was delivered at the 38fb week by 
Caesarean section.
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1). The less severe cases of toxaemia.
In this group of 18 cases, all were delivered 
of live babies which survived; there were 2 cases of 
twin pregnancy. The duration of toxaemia varied 
from 3 to 7 weeks before delivery and after admission 
to hospital with the institution of treatment (rest 
and sedatives) there was a clinical improvement in 
all the cases, and the pregnancies were continued 
until after the 37th week. The clinical findings 
are shown on Table 1, the highest blood pressure 
recorded was 160/100 mm.Hg. and the albuminuria 
varied from a trace to 2.5 g* per 1000 ml. but in 
one case albumen was not present. In 5 cases oedema 
was not detected.
Living babies were delivered by Caesarean 
section in two cases, and vaginally in sixteen cases. 
Surgical induction by artificial rupture of the 
membranes was performed in 11 cases. Foetal distress 
was not detected in any case. The average weight 
of the babies was 61b. loz. with a range of 51b.loz. 
to 71b. lOoz. The average weight of the placentae 
was 1 lb. 4oz. with a range of 1 lb. to 1 lb. lOoz.
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Fig. 1. . A SCATTER DIAGRAM 0E THE PREGNAEEDIOL
EXCRETION LEVELS, IE 18 CASES OE LESS 
SEVERE TOXAEMIA, WHO DELIVERED LIVE 
BABIES (Takle 2)
  Normal pregnaney range.
------- Average readings for normal pregnancy.
■------ Average raadings for Toxaemia Group.
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the twin pregnancies being excluded. Thus both the 
babies and placentae in this group were of average 
for an average duration of pregnancy of 38-g- weeks 
except 4 which were under lb.
The pregnanediol excretion (Fig.l, Table 2) 
was on the average low for the period of pregnancy.
Case 5 showed a subnormal excretion (17-5 mg. at 
the 39th week) with the low baby weight of 51b. 9oz. 
at 39 weeks' maturity. Case 10 showed a subnormal 
excretion at the 3Sth week but a slight rise at the 
39th week brought it into the normal range. Case 
17 showed a fall in excretion after the 33rd week, 
but it was not until the 37th and 38th weeks that 
the excretion became subnormal, surgical induction 
at the 38th week resulted in the spontaneous delivery 
of a live infant which weighed only 51b. 3oz.
Thus, of the 3 patients who showed subnormal excretion, 
only two were delivered of babies whose weight was low 
for the relevant gestation period. In cases 1, 2 
and 8 unduly small babies for the respective gestation 
period were also delivered, the pregnanediol excretion 
was within the normal range, but below the normal average
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Considering all the 18 cases of toxaemia in 
which the pregnancy was terminated after the 37th 
week, the babies were all over 5 lb. in weight, and 
the placental weight over one pound. The average 
pregnanediol excretion, although within the range 
for normal pregnancy was below the mean excretion for 
the relevant duration of pregnancy.
2). Cases of severe and fulminating toxaemia.
Of nine patients considered in this group, some 
improved slightly with bed rest and sedatives, but none 
completely recovered, and the pregnancy was terminated 
between the 34th and the 36th week in 8 cases and at 
the 38th week in the remaining cases. The clinical 
details are shown on Table 3* The blood pressure 
range was from 140/90 to 190/100 mm.Hg. and the 
albuminuria from 0.5 g./lOOO ml. to 8.5 g./lOOO ml., 
all the patients had oedema. Five cases were delivered 
by caesarean section, 3 vaginally after artificial 
rupture of the membranes, and one spontaneously.
They all had living babies which survived. The 
average weight of the babies was 31h• lOoz., the 
range being 21b. 12oz. to 41b. 15oz. There was thus
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gig. 2.’ .A SCATTER DIAGRAM OP THE PRE GEARED IOL 
EXCRETION LEVELS, IN 9 CASES OP 
SEVERE TOXAEMIA, WHO DELIVERED LIVE 
BABIES.
- Normal pregnancy range.
_______ Average readings for normal pregnancy.
_______ Average readings for the Toxaemia Group.
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Case Weeks of pregnancy.
No. 29 30 31 32 33 34 33 36 37
1 - 22.0 24.0
2 7.0 12.5 17.3 11.2 14.2 10.2
3 18.3 20.4 26.1
.. 4 27.2 20.3 21.4
5 18.1 20.0
6 12.0 14.0 16.0 14.3 14.0 14.5
7 16.9 12.3 13.8 11.9
8 10.4 8.1 10.0 17.8 19.1 21.7 24.0 13.3 .
9 16.0 12.8
Average 
Headings11.2 10.7 11.3 16.0 16.3 18.9 18.9 16.3 16.5
Normal
pregnancy 
Average 
Headings38.4 37.2 26.9 37.8 39.3 40.7 43.4 46.0 57.7
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a low average birth weight for an average duration of 
pregnancy of 36 weeks. One of the patients (Case 6) 
who was delivered by Caesarean section at the 38th 
week, had a 41b. 13oz. baby which was asphyxiated at 
birth and had convulsions with cyanotic attacks for 
2 to 3 days after delivery; it responded to treatment 
and survived.
The average weight of the placenta for this group 
was 15oz. ranging from 13 to 16oz. The pregnanediol 
excretion is shown on Pig. 2, and Table 4. It will 
be noted that the excretion in all but 2 cases was below 
the lower limit of the normal pregnancy range and. that 
the average excretion was well below that range. The 
excretion levels for cases 2, 7 and 8 are shown in 
Pigs. 3b and 4a and 4b., a fall in excretion was noted 
before delivery in each of these cases. The average 
excretion of pregnanediol in normal pregnancy falls at 
the 37th week, but in this group of cases the fall 
occurred between the 31st and 35th week and was 
associated with subnormal birth weights.
The pregnanediol excretion in case 6 is shown 
in Pig. 3a. It will be noted that a low level was
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Case 6. (Table 4) .
Baby 41b. 13oz.(alive)
S.I. Surgical Induction 
37 weeks.
Case 2. (Table 4)
Baby 21b. 12oz. (alive)
L.S.C.S. lower Segment 
Caesarean Section 
35 weeks.
Big. 3 b.
The pregnanediol excretion in 2 eases of severe
Toxaemia.
-—  - - Pregnanediol excretion.
 - __  Normal pregnancy range (lower limit)
______ Average readings for normal pregnancy.
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Case 8 (Table 4)
Baby 41b. 6oz.(alive)
L.S.C.S. (Caesarean 
Section) 36 weeks.
Weeks of pregnancy
Fig. 4a,
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>2 34 36 3<
Weeks of pregnancy
Case 7 (Table 4)*
Baby 31b. 8oz.(alive)
Spontaneous Delivery 
(35 weeks).
Fig. 4b. THE PREGNANEDIOL EXCRETION IN 
2 CASES OF SEVERE TOXAEMIA.
Pregnanediol excretion.
Normal pregnancy range.
Average readings for normal pregnancy.
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maintained till delivery at the 38th week. This is 
in agreement with the small size of the baby (41b.l3oz.)
Thus in this group there is good correlation 
between baby weight and pregnanediol excretion. An 
association between pregnanediol excretion and foetal 
prognosis cannot be posulated since all these babies 
survived.
Discussion.
In the two groups of toxaemia presented here, the 
only clinical difference was that the cases in the less 
severe group responded to rest and those in the severe 
group did not. The difference in pregnanediol 
excretion between the 2 groups was marked; the 
excretion was almost entirely subnormal in the severe 
group and almost entirely normal in the less severe 
group. The conclusion to be drawn is that subnormal 
pregnanediol values are associated with the types of 
toxaemia which are resistant to treatment and 
consequently low pregnanediol levels may indicate 
that the toxaemia is of this severe type. Live 
babies resulted from all these cases, so it cannot 
be concluded that low pregnanediol excretion is 
always associated with poor foetal prognosis; this
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conclusion is in agreement with that of Trolle (1955) 
but in disagreement with that of de Watteville (1951) 
and Richli (1953).
B. THE PREGNAHEDIOL EXCRETION IN PREGNANCY 
COMPLICATE!)- BY ESSENTIAL 
HYPERTENSION.
The patients in this group were all delivered 
of live babies which survived. A subdivision of cases 
is made into:-
1) Essential hypertension not complicated by toxaemia.
2) Essential hypertension complicated by toxaemia.
l). Essential hypertension not complicated by 
toxaemia.
Table 5 shows the clinical details of 12 patients 
with single pregnancies and one with twin pregnancy. 
Caesarean section was performed at the 36th week in 
2 cases and the remainder were delivered vaginally 
between the 37th and 41st week. In one case (Case 12, 
Table 5) foetal distress was noted after a 13 hour 
labour, but forceps delivery resulted in the birth of 
an asphyxiated baby which responded to treatment and 
survived.
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Pig. 5. A SCATTER DIAGRAM OE THE PREGNANEDIOL 
EXCRETION LEVELS, IN 13 CASES OE 
HYPERTENSION WITHOUT TOXAEMIA, WHO 
DELIVERED LIVE BABIES.
  Normal pregnancy range.
  Average readings for normal pregnancy.
  Average readings for hypertensive group.
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The lowest birth weights were found in the 2 
cases delivered by Caesarean section, 41b. loz., and 
41b. 8oz. The other babies weighed more than 51b. 8oz. 
The placenta of the 41b. loz. baby weighed 14 oz. and 
the others weighed over 1 lb. Thus both the birth 
and the placental1 weights corresponded with the 
appropriate gestation period except in the g cases 
delivered by Caesarean section. In one of these the 
baby and the placental weight was low and in the other 
the baby weight was low.
The pregnanediol excretion is shown in Fig. 5 
and Table 6. It can be seen that although some of 
the results lie below the level limit of the normal 
pregnancy range, the mean values lie within the range 
yet at a lower level than the mean values for normal 
pregnancy. Four patients had subnormal values,
Case 4 excreted 18.5 mg. at the 36th and 22 mg. at 
the 37th week when surgical induction resulted in 
the delivery of a normal baby weighing 51b. 8oz.
Case 10 has also a low pregnanediol excretion and 
Caesarean section at the 38th week resulted in the 
delivery of a live infant weighing only 41b. loz.
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with a placenta of 14-oz., these weights are low 
for this period of pregnancy. A low level of excretion 
was present in Case 11 but in spite of this a normal 
infant weighing 61b. 4oz. was delivered. Foetal 
distress after a 13 hour labour developed in the fourth 
case (Case 12) where low pregnanediol excretion was 
detected. Thus of four patients with low pregnanediol 
excretion, two had an uneventful delivery, in one there 
was poor foetel growth and one had foetal distress in 
labour. In the nine patients who had normal levels 
no signs of placental insufficiency in the form of 
foetal distress or poor growth of the baby was 
detected.
It may be concluded that in this type of case 
when the pregnanediol excretion is low, placental 
insufficiency is more likely to be present than 
when the excretion level is normal.
2). Essential hypertension complicated by toxaemia.
Table 7 shows the clinical details of the 10 
patients in this group. Six cases had toxaemia which 
responded to treatment and four had severe and 
fulminating toxaemia resistant to treatment. The
119.
former cases were delivered at the 37th to 40th week 
of pregnancy, either after artificial rupture of the 
membranes or spontaneous labour, the remainder had 
their pregnancies terminated at the 35th or 36th week 
by Caesarean section (3 cases) or artificial rupture 
of the membranes (1 ease) .
Foetal distress occurred in Case 8 where an 
accidental haemorrhage at the 36th week precipitated 
a decision for immediate delivery by Caesarean section, 
the infant weighed 31b. 6oz. at birth but cyanotic 
attacks occurred during the first four days of extra 
uterine death. Case 2 was delivered of a healthy 
infant weighing 51b. 7oz. although infarcts were 
present over 50^ of the placental surface. Macro­
scopic and microscopic examination showed the 
remainder of the placenta to be healthy.
The birth weights of the less severely toxaemic 
group ranged from 51b. 2oz. to 81b. 2oz. with an 
average of 61b. 2oz. The placental weights were also 
within the normal range. In the severely toxaemic 
group, the birth weights varied from 31b. 6oz. to 
51b. 2oz. (average 41b. 8oz.) yet the placental weights
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■Fig. 6. THE PREGNANEDIOL EXCRETION, IN 10 CASES
OE SEVERE PRE-ECLAMPTIC TOXAEMIA? WHO 
DELIVERED LIVE BABIES.
 *--- * Spontaenous delivery.
  Surgical induction.
 *... . Caesarean section.
"■ ■ Normal pregnancy range.
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were still within the normal range. The average 
duration of pregnancy in this group was 36 weeks so 
it is evident that the hahies* weights were subnormal 
for the gestation period.
The levels of pregnanediol excretions are 
shown in Pig. 6, individual graphs have been made 
for each patient. In three patients excretion was 
within the normal range and all three belonged to 
the less severe group of toxaemia. Two patients 
initially excreted subnormal amounts, but after the 
institution of treatment the excretion increased 
until normality was reached. These two patients 
belonged to the less severe group.
Pour patients had a consistently low excretion, 
and of these, 3 belonged to the severe group whilst 
the fourth patient (Case 2) had of the placental
surface replaced by infarcts (Pig. 7b). Case 8 
had a normal excretion but a gradual fall occurred 
which preceded and accompanied an accidental 
haemorrhage. The subnormal birth weights in this 
group correspond with subnormal levels of pregnanediol 
excretion.
123.
In this group of patients it has heen shown that 
the pregnanediol excretion varied with the severity of 
the toxaemia. In those eases where the toxaemia 
improved hut did not disappear altogether, the 
pregnanediol excretion rose into the normal pregnancy 
range. In one of these cases the placenta was 
grossly infarcted hut the functioning part was normal 
on histological examination and the pregnanediol 
excretion improved with rest and sedation; the hahy 
was of normal weight when delivered.
In cases where the toxaemic symptons were severe 
and did not respond to treatment, the pregnanediol 
excretion was lower or a fall in excretion was noted. 
The hahies survived although they were small for the 
period of gestation.
Discussion.
Ih: pregnancies associated with essential 
hypertension the pregnanediol excretion may give 
some indication of the rate of growth of the foetus 
and the functioning capacity of the placenta. In the 
majority of cases the excretion is within the normal 
pregnancy range but below the normal average, and the
124.
foetal development and prognosis is good. In some 
cases the excretion is subnormal and in these foetal 
development may be slow.
When pre-eclampsia is superimposed on the 
hypertension, the picture of pregnanediol excretion 
is slightly changed. If the toxaemia is responsive 
to treatment, the foetal growth and the pregnanediol 
excretion levels remain or become normal. If however 
the toxaemia does not improve, the foetal growth is 
retarded and the pregnanediol excretion is subnormal or 
becomes so.
It seems that the pregnanediol assay may be of 
use to the clinician in the management of this type of 
case. The general policy in the treatment of the 
hypertensive pregnant woman is rest, sedation of the 
patient and possibly the administration of hypotensive 
drugs. These measures are specially enforced when 
toxaemia becomes superimposed on the hypertension. 
Normal pregnanediol excretion may serve to reassure 
the obstetrician, whereas subnormal or falling levels 
may serve as a warning that either foetal growth is 
slow or the placental reserve is poor, particularly in
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those cases where the toxaemia is resistant to treat­
ment. The pregnanediol level may act as a guide for 
premature delivery in the difficult borderline cases.
C. TEE PREG-NANEDIOL EXCRETION IN 25 GASES OP
PRE-ECL1MPTIC TOXAEMIA OR ESSENTIAL HYPERTENSION
IN WHICH INTRA-UTERINE OR NEONATAL DEATH OCCURRED.
Pregnanediol estimations were made on 25 patients 
who had an intra-uterine or neonatal foetal death 
associated with pre-eclamptic toxaemia or essential 
hypertension. In 5 of these cases the additional 
complication of accidental haemorrhage occurred, the 
'two groups have been studied under a separate heading.
Gases not complicated by accidental haemorrhage.
Table 8 shows the clinical details of the 20 
patients in this group; all had hypertension, the 
blood pressure ranging from 190/140 mm.Hg. to 
154/90 mm.Hg.: 14 had albuminuria with from 0.25 to
8.0 of albumen per 1000 ml. of urine and 14 had oedema.
Neonatal death occurred in 5 cases (1 to 5), 
the babies being delivered by Caesarean section in 3 
cases and after a 14 and 24 hour surgically induced 
labour in 2. The birth weights at delivery were
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Eig. 8 . A SCATTER DIAGRAM OE THE PREGNANEDIOL 
EXCRETION IN 20 CASES OE TOXAEMIA,
WHERE THE EOETUS WAS EITHER STILLBORN 
OR DIED IN THE NEONATAL PERIOD.
*** Eoetus still alive when estimation 
made
••• Eoetal death occurred before 
estimation made.
Normal pregnancy range.
Average readings for toxaemia group.
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subnormal for a gestation period of 29 to 36 weeks.
In the remaining 15 cases the foetus died within 1 
and 4 weeks before delivery, the birth weights varied 
from 1 lb. loz. to 51i>» 8oz. with an average of 
31b. “koz. This is a low for the average duration 
of pregnancy which was 34 weeks.
The pregnanediol excretion in this group of 
patients is shown on Table 9 and Pig. 8 . In 7 of 
the cases studied (cases 6 to 12) it was not possible 
to obtain specimens before the foetal death but 
specimens were collected 1 to 14 days after the 
foetal death. It is assumed that these readings 
reflect the pre-death levels because in 5 cases 
(cases 13 to 17) where the pregnanediol excretion was 
determined before and 7 days after the foetal death, 
no appreciable fall was noted, and in the other 3 
cases (18, 19 and 20) only a slight fall ranging from
2.0 to 4.4 mg./24 hours was noted.
The mean readings for the 20 patients were well 
below the lower limit of the normal pregnancy range.
In 2 cases (18 and 19) the levels were initially 
normal but became subnormal before intra-uterine death
130.
Foetal death
§
a<oh
ft
10 -
10 15 20 25 30
Weeks of pregnancy
ffig- 9. Case 18. Table 9-
Baby 1 lb. 4-oz. (Foetal Death
at 26 weeks)
Normal pregnancy range.
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occurred. Case 18 developed severe toxaemia at the 
26th week of pregnancy and the baby died a few days 
later. The pregnanediol excretion had fallen in the 
2 weeks preceding the foetal death (Fig. 9) and there 
was a slow steady fall to 3.0 mg./24 hours during the 
remaining 4 weeks before delivery. The placenta was 
fibrotic and histologically no evidence of functioning 
placental tissue could be found. The foetal death 
was associated with an improvement in the patient’s 
general condition, the albuminuria improved and the 
blood pressure fell from-190/140 to 140/90 mm.Hg.
In the 7 cases where pregnanediol determinations were 
made after intra-uterine death a subnormal level was 
found in 5, and a normal level in 2 cases. It is 
unfortunate that specimens were not obtained in these 
cases before the death because there may well have been 
a downward trend in the excretion.
Thus in these cases where the pregnancy was 
complicated by hypertension or toxaemia, and intra-uterine 
or neonatal death occurred, a significantly low level of 
pregnanediol excretion was found. This was associated 
with subnormal foetal development and again demonstrates
sP-*
<4-i
-o iH 
cd A  
0  P  P  6 © ai •HO© ^ ft Q
a
&  p
s a
•H *H
PQ ,© 
e £
U 
© ©
o 
■3 fc
P  © 
•H  '
o Sz; 
W
vo
r -
cvi
3
I os ©
f t  ^  
CO P
-4
s fc! p 
o  P  © ftj
}25 R  no nn
O
V O
o
3
£
NO
IS
i
»
o
8**N
O -4* 
• •
vo r^
os
•
00
CM
CM
CM
n " \
0
3
1
3
O
-4 -
4
K >
CM
O N
O N
O N
CMrH
»
ON
CM
O
J
H
CsJ
3
4
N"N
»*N
ON
r-
vovo
CM
0
ON
CM
o
w \
, 3 f l
11.83
O
a
o
3
9
0J
4
4
-4
ON
VO
CM
O N
O N
O
o
* * \
©
£ ©
f t  §  
03 P
-4*
* N
f*N
w >
CM
O
3
>ITN
H
N
O
O
.—I
Kl
O
VO
A
N"N
LT\
3
132.
133.
that low levels of pregnanediol excretion may 
indicate that the foetus is developing slowly and 
that the placental reserve is already reduced. A 
further reduction may occur if the maternal toxaemia 
does not respond to treatment or if a further 
deterioration in the maternal condition occurs.
Cases not complicated by accidental ante-partum
haemorrhage.
Of the 5 patients in this group the clinical 
details are shown in Table 10; all patients 
were severely toxaemic and three had eclamptic fits 
preceding the haemorrhage. One was delivered by 
Caesarean section, 2 had labour induced and 2 
delivered spontaneously. Three of the infants were 
stillborn and 2 died in the neonatal period. The 
average birth weight was 21b. 15oz. This is low 
for an average duration of pregnancy of 32 weeks.
The placentae were examined and the diagnosis of 
Accidental Ante-partum Haemorrhage was confirmed.
The pregnanediol excretion before and after the 
haemorrhage is shown in Table 10. In all cases the 
level was normal before the haemorrhage and in 4 cases
134.
a subnormal level was found on the following day.
In the 5th case the level fell significantly but not 
to a subnormal level. These results accord 
confirmation of the fact that the pregnanediol 
levels are related to the amount of functioning 
placental tissue remaining after the haemorrhage 
and that a fall in pregnanediol excretion indicates 
a decrease in placental function and consequently 
reflects incipient danger to the foetus.
DISCUSSION.
It is a curious fact that there is no change 
of pregnanediol excretion preceding eclampsia or 
accidental haemorrhage in this small series. This 
seems to be at variance with a statement made in 
an earlier section, namely that the more severe 
type of toxaemia which is resistant to treatment 
is associated with low pregnanediol levels.
However in these cases the onset of the toxaemia 
was sudden and the duration of the symptons before 
the accidental haemorrhage ranged from 1 - 3  weeks 
and of the factors which contribute most to the 
reduction in placental function the duration of the 
toxaemia is one of the more important.
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D . ■ THE PREGNANEDIOL EXCRETION IN PREGNANCY
ASSOCIATED WITH CHRONIC NEPHRITIS.
INTRODUCTION.
In pregnancy associated with chronic nephritis 
the prognosis for the foetus is poor. The babies 
are small for the duration of pregnancy and the 
placentae small and insufficient. Pigeaud and 
Bureiul (194-7) showed that in these cases there was 
a relationship between the placental weight and the 
pregnanediol excretion in that when the placenta 
weighed under 1 lb., low levels of excretion were 
found and when it was between 1.5 and 1.9 lb. a 
higher excretion was present. They suggested that 
the foetal prognosis was worse when the impaired 
renal function was associated with hypertension. 
Trolle (1955) maintained that the presence of albumen 
in the urine in these cases, could give rise to 
fallacious results the albumen inducing a solid 
emulsion and making recovery of the pregnanediol 
difficult.
Pregnancy complicated by chronic renal disease 
is a rare condition but 5 patients were admitted to
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hospital during the time when this work was in 
progress, 4 had chronic nephritis and one chronic 
pyelonephritis with marked impairment of renal 
function.
RESULTS.
The clinical findings are shown in Table U.
The "blood urea varied from 29 to §0 mg. per 100 ml, 
albumen from 1.4 to 8 gm. per 1000 ml. and granular 
casts were found in all cases. The pregnancies were 
complicated by hypertension in all cases, the blood 
pressures varying from 160/100 to 200/100 mm.Hg.
The pregnancy in case 3 was terminated by 
hysterectomy at the 24th week because the patient's 
general condition was deteriorating: the blood
pressure was rising and the albuminuria increasing.
The baby was 1 lb. 2oz. in weight and lived for 5 
hours. The placenta weighed 6oz., it was unhealthy; 
there"was evidence of an accidental haemorrhage and 
histological evidence of insufficiency. The 
pregnanediol excretion was abnormally low (1.0 mg./
24 hours at the 21st week of pregnancy) and it remained 
low during the 3 weeks before delivery. In the first
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Pig. 10. THE PREGNANEDIOL EXCRETION IN 5 CASES 
OP PREGNANCY ASSOCIATED WITH CHRONIC 
RENAL DISEASE. (Table 11).
Pregnanediol excretion. 
Normal pregnancy range.
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24 hours following delivery, the patient excreted 
1.5 mg./24 hours (Pig. 10) and the excretion was only 
0.5 mg* on the 4th day of the puerperium. It is 
difficult to believe that a baby could grow to 
1 lb. 2oz. with a blood progesterone level indicated 
by a pregnanediol excretion which was at a similar 
level to that found in the proliferative phase of 
the menstrual cycle, yet a functioning placenta must 
have been present.
Oase I was somewhat similar to the above. The 
patient was delivered by Caesarean section at the 34th 
week of pregnancy, of a baby weighing 41b. 4oz.,
which lived for 6 hours. The placenta was 13oz. in 
weight, and there was an area of accidental haemorrhage 
and histological evidence of insufficiency. The 
pregnanediol excretion (Pig.10) was again abnormally 
low (3 to 8 mg.) throughout the pregnancy, the level 
being .3*5 mg. before delivery. In the 14 days after 
delivery the level varied from 1.2 to 0.4 mg./24 hours.
In case 5, Caesarean section was performed at 
the 33rd week of pregnancy and the baby which was 
only 21b. 5oz. in weight lived for 24 hours. The
140.
placenta weighed only 8oz. and about half of its 
functioning area was replaced by an infarct. The 
pregnanediol excretion in this case was low 
( 6 - 7  mg.) which was in agreement with the low 
birth weight of the baby and the poor functioning 
capacity of the placenta.
The duration of pregnancy at delivery in case 
4 was 39 weeks. The baby which was 51b. 12oz. in 
weight survived, after delivery by Caesarean section. 
The pl&centa weighed 16oz. and there was histological 
evidence of insufficiency. The pregnanediol 
excretion was maintained at a level of from 16 to 
21 mg./24 hours from the 27th to the 39th week of 
pregnancy. This is below the normal pregnancy 
range. In this case the low birth weight, the 
placental histology and the pregnanediol excretion 
were in agreement.
"Rhesus immunisation as well as chronic 
nephritis was present in case 4» The baby, a 
hydrops, died within 2 hours of birth, and the 
placenta, which was erythroblastatic, weighed 21b. 
9oz. The pregnanediol excretion was within the
141.
normal pregnancy range at the 29th week of pregnancy 
hut if fell to 17*0 mg./24 hours before delivery at 
the 30th week. It was the highest pregnanediol 
excretion noted in this series and corresponded with 
an enlarged and erythroblastatic placenta.
DISCUSSION.
Low levels of pregnanediol excretion were found 
in 4 patients whose pregnancy was complicated by
impaired renal function.
. .*
In one of these cases the excretion was 
maintained at a level just below the lower limit of 
the normal pregnancy range and the baby was small for 
a pregnancy of 39 weeks gestation (case 4). 
Histological evidence of placental insufficiency was 
found. This is in agreement with the results already 
reported in the section on toxaemia of pregnancy.
The findings in case 5 were similar; the pregnanediol 
excretion was 6*3 mg./24 hours and the baby weighed 
only 21b. 5oz. at the 33rd week of pregnancy. The 
placenta was grossly infarcted.
In the other 2 cases abnormally low levels of
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excretion were detected, and although placental 
insufficiency was probably present, it is difficult 
to believe that live babies can be produced with a 
functioning placental capacity inferred by a 
pregnanediol excretion of only 1.0 or mg./24 hours. 
It is possible that in these cases the pregnanediol 
excretion was not a true index of placental function 
and that the abnormally low levels were caused by 
failure of the kidneys to excrete the total amount 
of pregnancy formed by the placenta. If however the 
pregnanediol had been accumulating in the blood, then 
it should have been excreted in the puerperium when 
the renal function improved. This did not occur 
in the 2 cases studied. These cases were however 
only studied for periods of 4 and 14 days and the 
kidney function may not have recovered sufficiently 
during that time for the accumulated pregnanediol 
to be excreted. Pregnanediol before it is excreted 
by the kidneys is conjugated either in the liver or 
the kidney to pregnanediol glycuronide, which is 
water soluble. It is possible that if the kidney 
is the site of conjugation then in cases where the 
kidney function is impaired the conjugation is
143.
incomplete, and the kidneys may be unable to excrete 
pregnanediol which is insoluble in water. It may 
then be excreted by the alimentary tract or further 
metabolised.
In the last case the pregnanediol excretion 
was normal initially and then a slight fall occurred. 
The placenta was erythroblastotic and the cause of 
foetal death was Rhesus immunisation and not placental 
insufficiency.
These patients all had albuminuria and it was 
suggested by Trolle (1955) that this could cause an 
incomplete recovery of pregnanediol because solid 
emulsions, which are difficult to disperse, form 
in the toluene extracts of urines containing albumen. 
In the work reported here, the emulsions were broken 
down by adding 2 drops of "Teepol” (Shell Chemicals, 
London) to the extracts followed by washing with 
25 ml..N/NaOH containing 25$ NaCl.
This technique was used on 12 urines containing 
from 0.05 to 3 g. per 1000 ml. of albumen, to which 
0.4 mg. of pure pregnanediol had been added to 
150 ml. of urine. The recovery rates varied from
144.
T a b le  1 2 . T in i iu iC Q V jhtl OP r iit ta  P A J ik i^ iis D Iu L  lAON 
Uj.u.i\iiib) CONTAINING- AIAIMNN.
Clinical
Conditions
Albumen Pregnanedi ol 
excretion
Duration
of
Pregnancy-
Recovery
Chronic
pyelonephritis 0.3gms. 7 mgs. 29 weeks
Chronic
nephritis 1.5 gms 18.9 mgs. 25 weeks 93fc
Toxaemia 0.5 @ns. 17 mgs. 29 weeks lOCfk
Chronic,
nephritis 0.22gms. 2.0 mgs. 23 weeks 87>
hyp ert ensi on 0.05gms. 24.4 mgs. 30 weeks lOO'/o
Toxaania 0.5 gas. 10.2 mgs. 34 weeks 100,0
Toxaemia 0. 5 gas. 28,4 mgs. 29 weeks
&C
O
Toxaemia 0.5 gas. 10. 4 mgs. 30 weeks 91|
Toxaemia 0.55gas. 7.0 mgs. 30 weeks ioa/0
Toxaemia 0.2 gns. 9. 6 mgs. 28 weeks dO/o
Chronic
Nephritis 3.0 gms. 4*16 mgs. 20 weeks 91%
Chronic
Nephritis 0.75gnas. 8.9 mgs. 24 weeks
'&ON
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80io to 100c/o (Table 12.) , these are satisfactory 
recoveries for this method. This experiment only 
shows that free pregnanediol can be recovered from 
urines containing albumen and if the pregnanediol 
glycuronide is bound to the protein molecule some 
may be lost during extraction.
DISCUSSION AND PROPOSALS FOR FUTURE 
WORK.
This investigation was undertaken to establish 
the value of the urinary pregnanediol assay in the 
management of cases of toxaemia of pregnancy. The 
results obtained in the 75 eases have been grouped 
according to the patients' symptons, their response 
to treatment and the outcome of the pregnancy.
In the cases where the toxaemia was of the 
less severe type of where there was a good response 
to treatment (rest and sedatives) the- pregnanediol 
excret'ion was either within the normal pregnancy 
range or a subnormal level was found which became 
normal when the patient's toxaemia or hypertension 
improved. These patients were delivered between the
146.
57th and 40th week of pregnancy and the babies which 
were of normal weight survived.
Subnormal or falling levels of pregnanediol 
excretion were found in the patients who had a severe 
type of toxaemia, but who were delivered of live 
babies. The excretion levels in these cases appeared 
to give some indication of the foetal prognosis, 
because although duration of pregnancy at delivery 
was earlier than in the less severe group, the babies 
were of subnormal weight for the gestation period.
In the group who had stillbirths or neonatal deaths, 
in some cases very low levels of pregnanediol excretion 
were found (6 to 10 mg./24 hours) and the average 
excretion of the whole group was below the lower 
limit of the normal pregnancy range.
The results in these cases showed that, in 
cases of hypertension or toxaemia, the pregnanediol 
excretion gave some indication of the response to 
treatment, and of the final outcome of the pregnancy.
In the treatment of severe toxaemia the pregnancies 
are often not terminated before the 36th week because 
of the high foetal mortality from prematurity. In
147.
some of the cases presented here, intra-uterine 
foetal death occurred "before the 36th week of 
pregnancy and subnormal levels of pregnanediol 
excretion were found before the foetus died. The 
cause of the foetal death was probably anoxia caused 
by a gradual reduction in the functioning capacity 
of the placenta. Potter & Adair (1939) performed 
post mortem examinations on a large number of 
stillbirths and neonatal deaths and found that anoxia 
was one of the factors in which contributed to the 
high foetal mortality from toxaemia of pregnancy.
In cases, where a subnormal level of pregnanediol 
excretion or a significant fall in excretion is found, 
and clinically the baby does not appear to be growing, 
earlier delivery may prevent the foetus from being 
subjected to a prolonged period of anoxia and the 
foetal prognosis may be improved.
In this type of case it would be useful to 
correlate the cord blood oxygen saturation and the 
level of pregnanediol excretion. Clemetson & 
Churchman (1953)9 Walker & Turnbell (1953) and 
Walker (1954) showed that in toxaemia of pregnancy
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the cord blood oxygen saturation is reduced. Thus, 
if a relationship between the level of oxygen 
saturation, the pregnanediol excretion, and the fate 
of the foetus was found in cases of severe toxaemia 
it might be possible to establish the true pathological 
levels of pregnanediol excretion which indicate that 
the placental function is insufficient for the foetal 
requirements.
The factors which appear to have most influence 
on the pregnanediol excretion are the severity and the 
duration of the toxaemia and the maternal response to 
treatment. In 5 cases of fulminating toxaemia of 
short duration (l to 2 weeks) where the babies died 
from the effects of accidental haemorrhage the 
pregnanediol excretion was normal before, but subnormal 
after, the haemorrhage.
It has been assumed that the low pregnanediol 
levels“found in some cases of toxaemia may reflect the 
functioning capacity of the placenta and it is possible 
to correlate the pregnanediol excretion levels with 
low birth weights and with the foetal mortality.
There are however 2 other possible explanations for
149.
the low levels found, namely, that the kidney 
function was disturbed; or that when albumen is 
present in the urine, there is an incomplete recovery 
of pregnanediol. In 4 patients who had chronic 
renal disease, 2 excreted pregnanediol at the rate of 
6.3 and 21 mg./2-4 hours and 2 at 1.5 and 3.5 mg./24 
hours, the babies’ weights were subnormal in all 4 
cases and there was histological evidence of placental 
insufficiency. In these cases both a diminution in 
the progesterone production and the disturbed kidney 
function may have been responsible for the subnormal 
pregnanediol excretion. This could be proved if 
blood and urinary pregnanediol levels could be com­
pared but there is as yet no satisfactory method of 
estimating the blood pregnanediol (Klopper 1956,
Personal communication). It was decided that if 
pregnanediol clearance tests were performed on 
patients with low levels of pregnanediol excretion, and 
the rate of clearance compared with the normal pregnancy 
rate, the results obtained might show whether the 
injected pregnanediol was being retained. It is 
difficult to obtain pure pregnanediol commercially 
but 2 gms. of pure pregnanediol was prepared from
150.
200 litres of late pregnancy urine. A fine 
suspension of pregnanediol (50 mg.) in 2 ml. of 
eihyl oleate was injected into 3 members of the 
staff but no pregnanediol was recovered in the urine 
during the 7 days following the injection. Guinea 
pigs were then injected with a similar preparation 
of pregnanediol and 3 days later 75$ of the pregnane­
diol was recovered from the site of the injection.
The pregnanediol was probably not absorbed, because 
*.
it is insoluble in water but if sufficient quantities 
of pure pregnanediol glycuronide were extracted and
purified, this being water soluble would probably
be more suitable for the clearance test. The
results of this test might help to prove what
factors are responsible for the low pregnanediol 
excretion levels found in the toxaemias of pregnancy.
When pregnanediol was added to 12 urines 
containing albumen, satisfactory recoveries of 80$ 
to 100$ were obtained., It was thus assumed that the 
albumen present in the urine was not responsible for 
the subnormal levels of pregnanediol excretion found in 
toxaemia of pregnancy. Moreover in some cases of
151.
essential hypertension where albuminuria was not 
present low levels of pregnanediol excretion were 
found.
In some cases of toxaemia or hypertension where 
subnormal levels of pregnanediol excretion are 
initially found, a rise to normal levels may occur 
in response to treatment. In toxaemia and 
hypertension the blood supply to the uterus is 
reduced by spasm of the spiral arteries and this 
reduces the placental blood supply and may cause 
placental insufficiency. In those eases where a 
response to treatment is noted, the placental blood 
supply and function is probably improved, and this 
appears to be reflected by an increase in the 
pregnanediol excretion. This may be useful in 
determining the value of new forms of treatment in 
these conditions.
Summary and Conclusions.
The urinary pregnanediol assay appears to be of 
value in the management of cases of toxaemia of 
pregnancy, Normal levels have been found in cases 
where the foetal prognosis is good, and subnormal
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levels in cases where the toxaemia is complicated 
by intra-uterine or neonatal foetal death. A 
falling level below the normal pregnancy range, 
appears to be significant if the fall is maintained 
over a period of 2 or more weeks or if the fall is 
associated with a deterioration in the maternal 
condition.
The low levels of pregnanediol excretion found 
in toxaemia of pregnancy may not be caused by a fall 
in progesterone production. They may be due to 
either failure of the kidneys to excrete the 
pregnanediol produced or the incomplete recovery of 
pregnanediol from urines containing albumen. In 2 
cases of chronic renal disease abnormally low levels 
of pregnanediol excretion were found, but in the cases 
of toxaemia good correlation was found between the 
pregnanediol excretion level, the birth weight and 
the pl_acental histology. Satisfactory recoveries 
were obtained when pregnanediol was added to urines 
containing albumen and in cases of hypertension where 
albuminuria was not present low levels of pregnanediol 
excretion were found.
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It may thus be concluded that the pregnanediol 
excretion can reflect placental function in cases of 
toxaemia and that it may be used to assist in the 
management of cases where there is doubt about the 
foetal prognosis. This assay may also be of value 
in assessing the effects of treatment, i.e. by 
hypotensive drugs, in cases of severe toxaemia and 
hypertension in pregnancy.
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PART B .
THE PREGNANEDIOL EXCRETION IN CONDITIONS 
ASSOCIATED WITH POETAE DEATH IN LATE 
PREGNANCY.
It has been shown that in toxaemia of pregnancy 
subnormal levels of pregnanediol excretion may be 
found in those cases complicated by foetal death.
It was decided to investigate patients who had foetal 
deaths due to other late pregnancy disorders. The 
investigation was extended to include patients with 
a history of an unexplained stillbirth or neonatal 
death in a previous pregnancy and who were again 
pregnant.
The investigation is divided into 4 parts 
according to the associated condition :
A) Antepartum haemorrhage.
B) Diabetes mellitus.
--£) Rhesus immunisation, including eases of 
unexplained foetal death.
B) Bad obstetric history.
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A. THE PREGNANDIOL EXCRETION IN ANTE­
PARTUM HAEMORRHAGE.
INTRODUCTION.
Placenta previa and accidental Haemorrhage not 
associated with toxaemia or hypertension are two 
of the principal causes of vaginal bleeding in late 
pregnancy. In both these conditions there is 
partial separation of the placenta from the uterine 
wall and this may reduce the area of functioning 
placental tissue.
Patients admitted with a history of vaginal 
bleeding in the later weeks of pregnancy had pregnane­
diol estimations made at regular intervals until 
delivery. There were 20 cases investigated, the 
final diagnosis was placenta previa in 10 and in the 
other 10 cases a diagnosis of accidental haemorrhage 
was made.
RESULTS.
Placenta Previa G-roup.
The clinical details are shown on Table I 
In one patient twin babies were born at the 39th
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• Big. I. A SCATTER DIAGRAM OP THE PREG-NANEDIOL
EXCRETION LEVELS, IN 10 CASES OP
PLACENTA PREVIA (Table I).
j/;-- Normal pregnancy range.
 .... Average readings for tiie Placenta
Previa group.
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week of pregnancy, in the other cases living babies 
were delivered between the 35th and 39th week. 
Caesarean sections were performed in 7 cases and 
3 cases had spontaneous vaginal deliveries. The 
birth weights varied from 41b. 8oz. to 81b. 15oz., 
the average being 61b. 12 oz. which is normal for an 
average duration of pregnancy of 37 weeks although 
2 babies were small for the relevant gestation period 
(cases.2 and 6) and one of these babies died in the 
neonatal period (case 2).
The pregnanediol excretion Pig. 1., Table 1 
was within the normal pregnancy range but the mean 
values were below the mean values for normal 
pregnancy. It is of interest to note that in 
case 2 a significant and sustained fall within the 
normal pregnancy range occurred at the 36th week of 
pregnancy. This has been observed in normal 
pregnancy but in this case the baby's weight was 
subnormal and neonatal death occurred. The 
excretion level in the case of twin pregnancy was 
not higher than in normal pregnancy in spite of the 
excessive weight of the placenta (2-g-lb.) and the 
combined weights of the babies (11 lb. lloz.).
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Pig.2 . THE PREGNANEDIOL EXCRETION IN 10
CASES OE ACCIDENTAL ANTEPARTUM 
HAEMORRHAGE (Table 2).
------ Live birth Caesarean section.
u— __ « Live birth Spontaneous delivery.
•_____• Foetal death. ^ Time of foetal death.
-- Normal pregnancy range.
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Accidental Haemorrhage Group.
The clinical details of the 10 patients are 
shown on Table 2. Living babies were delivered 
vaginally in 4 patients, by Oaesarean section in 2 
patients and 4 patients had stillbirths. The 
average birth weight for this group was 41b. 15oz. 
which is low for an average gestation period of 
37 weeks. The diagnosis of concealed and revealed 
accidental haemorrhage was confirmed in all cases 
by examination of the placenta.
The pregnanediol excretion levels are shown 
on Table 2 and Fig. 2. The levels were normal
in 2 cases (4 and 9); both delivered live babies 
which were normally developed for the relevant 
gestation period. In 3 cases (2, 5 and 8) the 
pregnanediol excretion started to fall at the 27th 
(case 2) and the 33rd weeks (cases 5 and 8) and it 
had dropped below the normal pregnancy range before 
delivery. The normal pregnancy fall occurs between 
the 36th and 40th week. Live babies were delivered 
in these cases, 2 by Ceasarean section (cases 2 and 
8) and one spontaneously after a short labour (case 5).
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.Fig. 3 » Case 6. Table II (Accidental Haemorrhage) 
Baby 51b. (died 24 hours before delivery)
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163.
The babies survived although their birth weights were 
subnormal.
In the other 4 oases (3> 6, 7 and 10) stillborn 
babies of low weight for the gestation period were 
delivered and the pregnanediol excretion was again 
subnormal.
Thus, low pregnanediol levels can be correlated 
with slow foetal growth in the majority of these cases 
and persistantly subnormal levels with a poor foetal 
prognosis. fn view of these findings it is suggested 
that in cases of accidental antepartum haemorrhage 
a fallipg pregnanediol excretion, before the 36th 
week of pregnancy, may be used as an indication for 
early delivery, either vaginally or by Caesarean section 
and in cases where subnormal levels persist labour 
should be induced at an early date to avoid the 
incidence of intra-uterine foetal death.
DISCUSSION.
Haemorrhage in the later weeks of pregnancy 
from a low implantation of the placenta does not 
affect the pregnanediol excretion. The excretion
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in 10 cases of placenta previa was within the normal 
pregnancy range and the average birth weight of 
the babies, 61b. 5oz., was normal for an average 
duration of pregnancy of 37 weeks.
In the accidental haemorrhage group the 
pregnanediol excretion was either inititally below 
or fell below the normal pregnancy range in 7 cases 
and in 4 of these cases the babies were stillborn.
The average weight of the babies was low, 41b. 13oz.,
*
for an average duration of pregnancy of 37 weeks.
Thus in this group the pregnanediol excretion was 
lower than in the placenta previa group and the 
babies were smaller although the duration of pregnancy 
was the same in both groups. There were more 
stillbirths in the accidental haemorrhage group.
Thus, in placenta previa, although the placenta 
becomes partly separated from the uterine wall the 
separation is not due to an inherent fault in the 
placental vascularity or function and the pregnanediol 
excretion is often maintained at a normal level after 
the separation has occurred. In accidental haemorrhage 
the placental function is reduced, because the
165.
placenta is separated from the uterine wall by a 
retroplacental clot and the pregnanediol excretion 
may fall to subnormal levels after the haemorrhage 
occurs. In 3 of the cases presented here the fall 
in excretion occurred between 27th and 33rd weeks 
and placental insufficiency may have been present 
before the final haemorrhage at the 31st, 36th and 
37th weeks of pregnancy.
CONCLUSIONS.
"The pregnanediol excretion may give some guide 
£o placental function in cases of antepartum haemorr­
hage. A fall or a sustained low level of excretion 
may indicate that the foetus is in danger and if the 
pregnancy is sufficiently advanced for the baby to 
lead an independent existance delivery should be 
precipitated.
In accidental haemorrhage there is a reduction 
in the area of functioning placental tissue, and the 
baby may die from malnutrition. In this type of ease 
the pregnanediol excretion is subnormal and the birth 
weights are low and the incidence of intra-uterine 
foetal death is increased.
B. THE PREG-NANEDIQL EXCRETION IN DIABETES 
AND PREaNANCY.
INTRODUCTION.
The management of the pregnant diabetic is a 
difficult problem because in about 10$ to 30$ of 
cases the baby is stillborn or dies in the neonatal 
period. It has been shown that there is a fall in 
the pregnanediol excretion preceding intrauterine 
death in a number of cases (White & Hunt, 1940, and 
Smith & Smith 1947)• These workers presupposed 
that the low pregnanediol excretion was due to 
insufficient progesterone production. Working on 
these results White (1949) and Smith & Smith (1953) 
showed that the foetal survival was increased if 
replacement hormone therapy in the form of stilboestrol 
and progesterone was administered throughout pregnancy. 
Cray (1954) and Holland (1954) however found that in 
diabetic pregnancy the pregnanediol excretion was 
within the normal range and that the assay could not 
be used as a guide to foetal prognosis.
167.
PLAN OP INVESTIGATION.
Nineteen diabetic patients, all having insulin 
therapy, were kept under observation throughout 
pregnancy. The diabetes was diagnosed during 
pregnancy in 2 cases and between 1-g- and 10 years 
before the pregnancy in the remaining seventeen.
The duration of pregnancy at delivery varied from 34 
to 40 weeks and the babies’ weights from 5 to 7 pounds, 
there were 4 stillbirths. Three patients had 
hypertension in early pregnancy and intrauterine 
foetal death occurred in one of them. Two patients 
developed pre-eclamptic toxaemia during pregnancy 
but both delivered live babies. The other 3 
stillbirths, all the result of antepartum foetal 
death, occurred in patients who had no complications 
other than diabetes. In 15 cases live babies were 
delivered either by Caesarean Section (9 cases) or 
spontaneously after surgical rupture of the membranes 
(6 cases). Pregnanediol estimations were made at 
regular intervals after the 28th week of pregnancy 
in all cases.
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ffig. 4 . A SCATTER DIAGRAM OF THE PREGHANEDIOL 
EXCRETION LEVELS, IN IS PATIENTS WHO 
HAD DIABETES AND DELIVERED LIVE 
BABIES.
xx Uncomplicated diabetes.
•• Diabetes complicated by hypertension 
or toxaemia.
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RESULTS.
The pregnanediol excretion in the live birth 
group is shown in Table 3 and Eig. 4. The excretion 
was within the normal pregnancy range except in cases 
3 and 4. Case 3 was one of the cases of essential 
hypertension (180/110) mm.Hg.) and case 4 had toxaemia 
with albuminuria (| to 2 gm./lOOO) and hypertension 
(150/100 mm.Hg.). Live babies which survived were 
delivered by Caesarean section in both these cases.
Table 4 and Eig. 5 show the pregnanediol 
excretion in 4 cases where intra-uterine foetal death 
occurred. In all cases the pregnanediol excretion 
level was maintained for 7 to 14 days after foetal 
death had occurred. Eig. 6 shows the pregnanediol 
excretion in one of these cases who had daily 
estimations made for 9 days after the foetal death 
and then every third day until delivery. The 
excretion was 32 mg./24 hours 16 days after the foetal 
death and there was a gradual fall during the next 3 
weeks until a level of 15 mg./24 hours was found 
before delivery. The birth weights of the babies in 
this group varied from 6 to 7i lbs. although foetal
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Pig. 5. THE PREGHAHEHIOL EXCEETIOH IH 4 CASES
OP POETAL HEATH IH HIABETIC PREG-HAHCIES. 
(Table 4) .
* Indicates where the foetal death occurred.
Hormal pregnancy range.
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Fig. 6. Case 1. Table 4.
THE PREGNANEDIOL EXCRETION IN A CASE OF 
FOETAL DEATH FROM DIABETES.
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death occurred “between the 33rd and the 35th week of 
pregnancy. The weights was thus increased relative 
t© the duration of pregnancy.
DISCUSSION.
Nineteen diabetic pregnant patients had regular 
pregnanediol estimations made after the 28th week of 
pregnancy. Fifteen of these had live births and 4 
had stillbirths.
The pregnanediol excretion in the group who 
delivered living babies was within the normal pregnancy 
range except in 2 cases, one complicated by hypertension 
and the* other by toxaemia. It seems likely that the 
cause of the low pregnanediol in these cases was not the 
diabetes but the complication, namely the hypertension 
and the toxaemia.
The pregnanediol excretion in the 4 cases where 
intrauterine foetal death occurred was maintained at 
a normal level for a period of 7 to 14 days after the 
foetal death. These results suggest that the placenta 
continues to live after the foetus dies. They are 
in agreement with those of Rolland (1954), who, using
175.
the method of Marrian, Sommerville & Kellar (1948) 
showed that the overall picture for the pregnanediol 
excretion in 44 diabetic pregnant patients, 12 of 
whom had stillbirths, differed little from that 
obtained in normal pregnancy. They are however at 
variance with those of Smith & Smith (1947) who, 
using the method of Venning (1938) showed that there 
was a low pregnanediol excretion in pregnancy 
diabetes. White (1949) used the findings of Smith 
& Smith (1947) as a basis for hormone therapy and 
showed an increase in the foetal survival when 
progesterone and oestrogen were administered in 
pregnancy diabetes. Peel (1955) was unable to show 
any significant increase in the foetal survival in 
diabetic patients treated with stilboestrol therapy. 
The results reported here indicate that progesterone 
production is normal in the diabetic pregnancy and 
consequently there is no rationale for replacement 
hormone therapy.
CONCLUSIONS.
The diabetic pregnant woman has a normal 
pregnanediol excretion.
176.
Subnormal levels were found in two cases where 
live babies were born. One of these cases was 
complicated by hypertension and the other by toxaemia 
and thus the low values of pregnanediol excretion 
could have been due to the complications and not to 
the diabetes.
In 4 cases where intrauterine foetal death 
occurred the pregnanediol excretion was maintained at 
a normal level for 7 to 14 days after the foetus had 
died. It is postulated that placental insufficiency 
was not the cause of the foetal death in these cases.
It may thus be concluded from this small series 
that the pregnanediol assay is of no value in 
determining the outcome of the pregnancy in 
uncomplicated diabetes since a normal level of 
excretion can be maintained before and for sometime 
after intrauterine foetal death.
Pr
eg
na
ne
di
ol
 
mg
./
24
 
ho
ur
s
177.
60-
30-
10.'
24
Weeks of pregnancy
Fig. 7 . THE PEEG-NANEDIOL EXCRETION IE 5 
GASES OF FOETAL DEATH ASSOGIATED 
WITH RHESUS IMMUNISATION (Table l).
V  Indicates when the foetal death occurred. 
  Normal pregnancy range.
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C. THE PREGNANEDIOL EXCRETION IN CASES OP 
POETAL DEATH PROM RHESUS IMMUNISATION 
AND PROM CAUSES UNKNOWN.
It Has been shown that in cases of foetal 
death in the diabetic patient normal levels of 
pregnanediol excretion may be found for 7 to 14 
days after the foetal death. Cases of intra-uterine 
death from Rhesus immunisation and from unknown 
causes were next investigated.
The pregnanediol excretion in 5 cases of foetal death 
associated with Rhesus immunisation.
Pregnanediol estimations were made at regular 
intervals throughout pregnancy in 5 patients who were 
sensitised to the Rhesus antibody. Intra-uterine 
death occurred in all cases between the 27th and 
36th week of pregnancy, the birth weights varying 
from 1 lb. loz. to 61b. 7oz. with an average of 
31b. 12oz. which is considered normal for the average 
gestation period of 31 weeks.
The results of the pregnanediol estimations are 
shown on Figure 7 and Table 5* H  will be noted
that except in case 1 , the excretion was within the
180.
normal pregnancy range before and after the foetal 
death. In case 1 a significant drop (9 mg./24 hours) 
was noted before the foetal death and a level just 
below the lower limit of the normal pregnancy range 
was maintained for 19 days afterwards. This is the 
only case in which a subnormal birth weight was 
present ( 1 lb. loz. at the 28th week of pregnancy).
In case 2 the placenta weighed 41b., the pregnanediol 
excretion was within the normal pregnancy range but 
the baby, a hydrops, was heavy (61b. 7oz.) for a 
32 weeks' gestation.
It has been shown that in some cases of foetal 
death associated with Rhesus incompatibility, normal 
levels of pregnanediol excretion are found before and 
after the foetal death. The cause of the foetal 
death in Rhesus immunisation is often erythroblastosis, 
not placental insufficiency. Thus the placenta can 
continue to function and produce hormones after the 
foetus has died. The placental function can be 
demonstrated by the level of pregnanediol excretion.
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The pregnanediol excretion in 5 gases of foetal 
death of unknown aetiology.
The clinical findings of this group are shown 
in Table 6. Of the 5 patients, 3 had foetal deaths 
between the 30th and 37th week of•pregnancy and 2 
between the 40th and 41st week. The cause of the 
foetal death was not known in any of these cases.
In cases 1 and 2 the babies’ weights were subnormal 
for the gestation period at the time of foetal death, 
but normal in the remainder.
The pregnanediol excretion is shown on Table 6. 
In cases 1 and 2, subnormal levels were found 2 and 
4 days after the foetal death; in case 3, the level 
was within the normal pregnancy range 4 days after 
the foetal death. In cases 4 and 5, normal levels 
were found 2 and 4 days before and 1 and 2 days after 
the death of the foetus. The birth weights were 
subnormal in the cases where a subnormal excretion 
was found, and normal when the excretion was normal. 
Thus it may be assumed that in cases 1 and 2 placental 
insufficiency, judged by the subnormal weights of the 
babies and the low pregnanediol levels, was present,
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and that if the foetal death in cases 3> 4 and 5 
was caused by placental insufficiency, this was not 
demonstrated by the level of pregnanediol excretion 
or by the birth weights of the babies.
Summary and conclusions.
In 3 cases of foetal death of unknown aetiology
and in 4 cases from Rhesus immunisation normal levels
of pregnanediol excretion were found after the foetal 
death. The birth weights were normal for the 
gestation period except in one case associated with 
Rhesus immunisation where the baby, a hydrops, was 
61b. 7oz. at the 32nd week of pregnancy.
In 2 cases where the aetiology of the foetal
death was uncertain, the pregnanediol excretion levels 
after the foetal death were subnormal for the gestation 
period and the birth weights were subnormal. Thus 
the cause of the foetal death was probably placental 
insufficiency. a fall in pregnanediol excretion to 
a subnormal level was found before the foetal death 
in one of the eases of Rhesus immunisation, but the 
baby's weight was subnormal.
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It may be concluded that in some cases of 
foetal death of unknown aetiology or from Rhesus 
immunisation, the placenta can continue to function 
after the foetus has died and pregnanediol is 
excreted at a normal level. The cause of the 
foetal death in other cases may be placental 
insufficiency and in these cases subnormal or 
falling pregnanediol excretions are associated with 
subnormal baby weights.
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D. THE PREGNAIEDIOL EXCRETION IN GASES WHERE 
THE OBSTETRIC HISTORY WAS POOR.
Patients who have had an unexplained stillbirth 
or neonatal death are difficult to manage in a future 
pregnancy. There is always a possibility that the 
baby will again be stillborn but at present there is 
no'- test which will detect incipient f,foetal distress". 
This investigation was undertaken to establish the 
value of the pregnanediol excretion in these cases, 
both to detect placental insufficiency and to 
determine when the baby should be delivered.
The patients in this group had a history of 
one or more stillbirths or neonatal deaths in a 
previous pregnancy. Details of the obstetric history 
and the method of delivery are given in all cases.
Case I. (Mrs. C.) age 30 years, had had a 
history of 3 abortions and a neonatal death of a 
baby weighing 51bs. 9ozs. at the 36th week of 
pregnancy. In the next pregnancy she was admitted 
to hospital at the 27th week on account of premature
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-Fig. I. Case I. 6586/55- J-H.W.
1949 - Neonatal death 5-1 lb-16
1951 - Abortion.
1952 - Abortion.
1954 - Abortion.
1955- Baby 3-1 lb. (alive) 
Placenta l l  lb. 
Spontaneous delivery.
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ne- II. Case 2. Mrs. L. 1428/55 J.H.W.
1953 - Neonatal death. Pull term
31b.
1954 - Abortion
1955 - Caesarean section.
Baby 41b. 14oz. (alive). 
Placenta 1 lb. 2oz.
Lower limit of the normal pregnancy 
range.
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rupture of the membranes and at the 35th week she had 
a spontaneous vaginal delivery, the baby weighing 
31b. loz. The size of the baby was small for a 
pregnancy of 35 weeks maturity, but it survived.
The placenta weighed 1 lb. 3oz. and was normal.
The pregnanediol excretion is shown on Pig. 1.
There was a fall below the normal pregnancy range at 
the 23rd week and then a low level was maintained 
until delivery. The correlation between the low 
birth weight and the low pregnanediol excretion is 
to be noted. Delivery in this type of case is often 
witheld until the foetus is approximately 51b. in 
weight. Such a decision was not to be made as in 
this case spontaneous labour ensued. However it is 
suggested that the maturity rather than the size of 
the foetus should be taken into account in the 
decision to induce since the growth of the baby 
appears to be slow in cases where a low pregnanediol 
excretion is present.
Case II. (Mrs. L.), age 2 5 years, had a 
history of an abortion following a stillbirth 
weighing only 3 lb. at the 40th week of pregnancy.
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■Fig. III. Case 3. Mrs. W. 7198/56. J.H.W.
1953 - Neonatal death 28 weeks
1954 - Neonatal death 28 weeks 
1956 - Live birth 81b. 8oz.
Placenta - 1 lb.
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She remained well throughout the next pregnancy but 
the growth of the uterus was poor in comparison with 
the duration of amenorrhoea and Caesarean Section was 
performed at the 36th week. The baby weighed 
41bs. 14oz., which was small for a 36th week pregnancy 
but it survived. The placenta, 1 lb. 2oz. in weight, 
showed a few small areas of infarct and on histological 
examination signs of ageing and insufficiency was found. 
The pregnanediol excretion (Pig. II) was at the lower 
limit of the normal pregnancy range but there was a 
fall just before delivery. This is in agreement 
with the slow foetal growth and the placental histology 
and in association with the history could have been 
used as an indication for delivering this patient 
at the 36th week of pregnancy.
Case III. (Mrs. W.) had had stillbirths at the 
26th week of her 2 previous pregnancies. In the next 
pregnancy the uterine size increased slowly and at the 
37th week it was decided to induce labour surgically.
A living 51b. 8oz. baby, which survived, was delivered 
vaginally after a 6 hour labour. In this case the 
pregnanediol excretion (Pig. Ill) was maintained at
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Fig. IV. Case 5- 33692/56. C.G.H.
1954 - Stillbirth 36 weeks
31b. 3oz.
1955 - Stillbirth 34 weeks
31b. 4oz.
1956 - Surgical induction 38 weeks.
Baby 6 lb. (alive)
Placenta 1 lb. loz.
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a level below the lower limit of the normal pregnancy 
range from the 31st to the 37th week of pregnancy.
The significance of this observation is uncertain as 
the baby was of reasonable weight and the placenta 
1 lb. in weight was normal.
Case IY. (Mrs. H.) had a history of 2 
intrauterine foetal deaths, one following an accidental 
haemorrhage. She was well throughout the next 
pregnancy and the baby continued to grow normally.
She delivered a living 81bs. Og-oz. baby at the 39th 
week. The duration of labour was 3 hours and the 
placenta appeared to he healthy and weighed 1 lb. 8ozs. 
The pregnanediol excretion at the 37th week was 
58 mg./24 hours and at the 39th week it was 49 mg./
24 hours. Thus the normal excretion levels in this 
case agreed with the good placental function and 
normal growth of the haby.
In her previous pregnancies, Case V., (Mrs. R.) 
had had 2 stillborn babies weighing 31b. 3oz. and 
31bs. 4oz. and at the 36th and 34th weeks. In the 
next pregnancy the uterus continued to grow normally 
and labour was induced surgically at the 37th weeks.
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Fig. T . Case 6 . 58189/56 C.G.H.
10
1944 _ Neonatal death. Pull term 4^5 lb*
1946 - Stillbirth 32 weeks.
1947 - Stillbirth 32 weeks.
1956 - Caesarean section.
Baby 51b. 12oz. (alive)
Placenta 1 lb.
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A living 6lb. baby was delivered and the placenta 
weighed 1 lb. loz. and was healthy. The pregnanediol 
excretion maintained at a normal level until delivery 
(Pig. IV) tallied with the successful outcome.
Case VI. (Mrs. A.) age 35 years, had been 
married 10 years and her 3 previous pregnancies had 
resulted in the delivery at the 40th week of a 
41b. lOoz. baby which died during labour, and 2 
stillbirths at the 32nd week of pregnancy. Her 
next pregnancy was uncomplicated and a living 51b. 
12oz. baby was delivered by Caesarean section at the 
35th week. The placenta weighed 1 lb. and on 
histological examination evidence of ageing and 
insufficiency was found. The pregnanediol 
excretion (Pig. V) was normal but started to fall 
at the 32nd week until at the 35th week it was below 
the lower limit of the normal pregnancy range. This 
fall could have been related to the senile changes 
which had occurred in the placenta and have been used 
as an indication for terminating the pregnancy.
Case VII. (Mrs. P.) had had one normal delivery 
followed by 3 stillbirths and an abortion. In her 
next pregnancy vaginal bleeding occurred at irregular
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Fig. VI. Case 7- Mrs. P. 360/55. J.H.W.
1943 - Normal full term delivery 
1947 - Stillbirth 28 weeks
1953 - Stillbirth 29 weeks
1954 - Stillbirth 32 weeks
1955 - Caesarean section
Baby 51b. 4oz. (alive) 
Placenta 1 lb.
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intervals and she was kept in hospital from the 8th 
to. the 56th week when the membranes ruptured 
spontaneously and the foetal heart became irregular.
A living 51b. 4oz. baby was delivered by Caesarean 
Section. The placenta weighed 1 lb. 4oz. and it 
appeared to be healthy on macroscopic and histological 
examination. Pregnanediol estimations (Pig. VI) madb 
at regular intervals of 3 to 5 days throughout 
pregnancy, remained within the normal pregnancy range 
and reached a level of 54 mg./24 hours before delivery. 
In this case the pregnanediol excretion was in agreement 
with the placental histology. The cause of the 
continued vaginal bleeding may have been placental 
separation but it had no effect upon the pregnanediol 
excretion, the growth of the placenta nor of the baby.
It is possible that the irregularity of the foetal 
heart was due to a cause other than placental 
insufficiency, since the pregnanediol excretion was 
high; the most likely cause was rapid engagement 
of the foetal head when the membranes ruptured in 
this muMparous patient.
Case VIII. (Mrs. B.) had a history of a neonatal
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Big. VII. Case 8 . Mrs. B. 4755/55- J.H.W.
1952 - Neonatal death
1953 - Abortion
1954 - Abortion
1955 - Spontaneous delivery
(Poetal distress)
Baby 81b. lOoz. (alive) 
Placenta 1 lb. 14 oz.
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death, and 2 abortions in previous pregnancies. The 
next pregnancy was prolonged for 6 days after the 
expected date of delivery when labour occurred 
spontaneously and lasted 10 hours. There was "foetal 
distress" in the second stage of labour and the baby 
was asphyxiated at birth but it responded to 
..resuscitation and survived. It weighed 81b. lOoz. and 
the placenta weighed 1 lb. 14-oz. Histologically the 
placenta showed evidence of poor function and 
postmaturity. The pregnanediol excretion (Pig.VI) 
was within the normal range till the 40th week when 
it dropped to 17 mg./24 hours. In view of the 
placental histology it seems probable that the cause of 
the foetal distress was placental insufficiency. It 
is reasonable to deduce that the fall in pregnanediol 
excretion was due to the reduced placental function 
and it is tempting to suggest that drop in excretion 
could have been used as the indication for immediate 
delivery in this case.
DISCUSSION.
The cause of the stillbirth and neonatal deaths 
in previous pregnancies in this group of patients was
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not known but it is possible that placental 
insufficiency may have been present in some of the 
cases where small babies, born at term, did not 
survive. This complication could have recurred 
in subsequent pregnancies. It is difficult to 
assess the growth of the foetus clinically but it 
may-be possible to demonstrate placental function 
by the pregnanediol assay.
A normal level of pregnanediol excretion was 
found in Cases IV, V, and VII who delivered live 
babies of average weight for the gestation period.
In Case VII irregularity of the foetal heart was 
detected immediately the membranes ruptured but this 
may have been caused by the sudden engagement of the 
foetal head and not by placental insufficiency, the 
placental histology was in agreement with the 
pregnanediol excretion.
The fall in excretion noted in Case II, VI 
and VII was associated with placental senility 
detected on histological examination. living babies 
were delivered by Caesarean section at the 35th week 
in Cases II and VI and spontaneously after a 10 hour 
labour in Case VIII, foetal distress was noted before
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delivery in this case.
Cases I and III had low normal levels followed 
by a maintenance of excretion instead of a rise.
The excretion in Case I remained at the low level of 
14 mg./24 hours till delivery at the 35th week of 
pregnancy. The clinical association in this case 
was the low weight of the baby which was only 31bs.loz. 
at the 35th week. The other foetus which was of 
low weight in relation to the maturity was Case II 
where a falling pregnanediol Ibvel was detected. A 
reasonable explanation cannot be found for the 
subnormal values detected in Case IHand no clinical 
association was found.
CONCLUSIONS.
The results of the pregnanediol assay in this 
small series of cases where the obstetric history 
was poor lead to the following conclusions. Normal 
pregnanediol values suggest that the foetus is growing 
normally and that a successful outcome of the pregnancy 
can be anticipated.
Values which suddenly fall may indicate that
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the placenta is showing signs of ageing and insufficiency 
and that delivery should not he postponed.
Consistently low values are of doubtful 
significance but in these cases the growth of the 
foetus may be slow and the maturity rather than the 
foetal size should be taken into account when the 
decision for induction of labour is weighed.
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GENERAL SUMMARY AND CONCLUSIONS.
Some of the results presented in this section 
confirmed the opinions already expressed in the 
section on toxaemia of pregnancy in that a relationship 
was found between the subnormal levels of pregnanediol 
excretion and subnormal birth weights in cases of 
accidental antepartum haemorrhage, foetal death of 
unknown aetiology and in patients with a poor 
obstetric history. In some of these cases histolo­
gical evidence of placental insufficiency was also 
found.
A normal level of pregnanediol excretion was 
found in 17 cases of uncomplicated diabetes and in 
4 of these cases the level was maintained for 7 to 
14 days after the foetal death had occurred. Similar 
results were obtained in 4 cases of intra-uterine 
death from Rhesus immunisation and 3 cases of foetal 
death of unknown aetiology.
Good correlation was found between pregnanediol 
excretion and the clinical findings in the group of 
patients who had a poor obstetric history and it 
was decided that the assay was of value in the
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management of these cases.
It may be concluded that the pregnanediol assay 
may be of value in the management of some cases of 
accidental haemorrhage, diabetic pregnancy complicated 
by toxaemia and hypertension, and in cases where the 
obstetric history is poor.
When a small series of cases of foetal death 
from Rhesus immunisation and foetal death of unknown 
aetiology were investigated the results showed that 
placental function was maintained at a normal level 
before, and for some time after the foetal death had 
occurred.
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PINAL SUMMARY AND CONCLUSIONS.
This work was undertaken to establish whether 
or not the urinary pregnanediol assay could be used 
as an indication of placental function in abnormal 
pregnancy.
A biochemical survey of two precipitation 
methods and of the chromatographic method of Klopper, 
■‘Hichie & Brown (1955) proved that the chromatographic 
method was the most accurate.
The blood "progestation activity" and the 
urinary pregnanediol excretion were compared in 10 
normal women at the 34 to 36th week of normal pregnancy. 
No correlation was found between the two.
The daily variation on 3 consecutive days, in 
the pregnanediol excretion in these ten women, at the 
same period of pregnancy was found to be insignificant.
Regular estimations were made during pregnancy 
on 24 patients and the normal pregnancy range was 
established. A peak level of excretion was found 
between the 36th and 38th week, and there was a fall 
just before delivery in the majority of cases. The
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excretion before and after delivery was studied in 
detail and only a slight fall in excretion was found 
on the day following delivery.
The range of excretion in early normal pregnancy 
is very wide, and for this reason the assay proved to 
be of limited value in the management of cases, of 
recurrent and threatened abortion.
In 6 cases of recurrent abortion stilboestrol 
therapy neither increased nor decreased the pregnanee 
diol excretion, and using the progesterone recovery 
test of Gruterman (1953) it was impossible to foretell 
the outcome of a pregnancy in cases of threatened 
ab or t i on.
Evidence was presented to show that the 
pregnanediol excretion may reflect placental function 
in cases of severe toxaemia. In many cases a relation­
ship between the pregnanediol excretion, the birth 
weight and the placental histology was shown. Other 
factors which might be responsible for altering this 
relationship have been discussed.
In some cases of non-toxic accidental antepartum 
haemorrhage the same relationship between the
pregnanediol excretion, the hirth weight and the 
placental histology was noted.
A small series of cases of diabetes in pregnancy 
was investigated, and the pregnanediol excretion in 
uncomplicated diabetes was found to be normal. In 
cases of intra-uterine death, normal levels were found 
in diabetes, Rhesus immunisation and in foetal death 
of unknown aetiology.
It may be concluded that the urinary pregnanediol 
assay can be used to indicate placental function in 
some abnormal conditions of late pregnancy. The 
results obtained may give considerable assistance to 
the clinician, in assessing cases where a reduction 
in the functioning capacity of the placenta is 
suspected.
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